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Abstract 
 
Alcohol abuse induces many disorders including depression, metabolic syndrome, and 
sleep disturbances. The strong link between alcohol abuse and sleep problems, along 
with the close connection between sleep and circadian rhythms, led us to investigate 
ethanol’s effects on the circadian clock. Previous work has shown that acute ethanol 
blocks photic phase shifts in vivo and glutamatergic phase shifts in vitro. However, neural 
systems become tolerant to ethanol across different timeframes. Despite both ethanol 
tolerance and ethanol withdrawal syndrome being listed as criteria for developing alcohol 
use disorders, little is known about how ethanol tolerance and withdrawal induced 
hyperexcitability develop and how they differ. Because previous work has shown that 
acute tolerance to ethanol occurs in the SCN, we tested whether additional forms of 
tolerance as well as withdrawal induced sensitization develop in the SCN and we 
identified distinct changes across all of these conditions with respect to N-methyl-d-
aspartate (NMDA) receptor related proteins. Our hypotheses were that rapid tolerance, 
chronic tolerance, and withdrawal induced sensitization occur in the SCN, that these 
conditions are associated with increased expression of NR2B containing NMDA 
receptors, and that the extent to which these changes occur differ across tolerance and 
withdrawal paradigms. We found that rapid tolerance develops in vivo and in vitro with 
respect to a loss in phase shift inhibition. Additionally, we have discovered chronic 
tolerance and withdrawal induced sensitization to glutamate also occur in vitro. 
Furthermore, we compared phosphorylation and total expression of NMDA receptor 
subunits and NMDA receptor-regulating proteins across the drinking models that induce 
rapid tolerance, chronic tolerance, or withdrawal. We found no changes during rapid 
tolerance to ethanol. In contrast, we saw an increase in the ratio of total expression of 
vi  
NR2B/NR2A during both chronic tolerance and withdrawal from EtOH, an increase in Tyr 
1472 phosphorylation during withdrawal, and an increase in mature BDNF and TrkB 
phosphorylation during withdrawal. Altogether we demonstrated the power of utilizing the 
SCN for investigating ethanol induced plasticity by identifying rapid tolerance, chronic 
tolerance, and withdrawal induced sensitization. Additionally we found that the cellular 
effects of ethanol during these forms of tolerance and withdrawal differ. 
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Chapter 1 
General Introduction 
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Background 
Alcohol causes a wide range of changes in the physiology, cell signaling, and 
genetic regulation of many brain regions. Prolonged use of alcohol can lead to alcohol 
use disorder (AUD). The diagnostic statistical manual of mental disorders volume 5 
(DSM-V) suggests that the two primary components of AUD are drug seeking and drug 
dependence (APA, 2013). Focusing on the latter, the criteria describing dependence 
includes seeking alcohol even when aversive to health, cravings, developing tolerance, 
and experiencing symptoms of withdrawal after sudden abstinence (Hagman and Cohn 
2011; APA, 2013). The neurocircuitry mediating the effects of alcohol relevant to the 
development of addictive behavior include the prefrontal cortex, amygdala, nucleus 
accumbens, hypothalamus, thalamus, and ventral tegmental area (Noori et al 2012). 
However, ethanol (EtOH) modifies signals in many other regions of the brain that have 
been used to investigate EtOH related phenomena. In this research we focused on the 
suprachiasmatic nucleus (SCN) in the lower hypothalamus, as a model system for 
studying EtOH tolerance and withdrawal. 
The SCN houses the endogenously driven primary oscillator that regulates the 
timing of circadian rhythms over 24 hours. The firing rate of neurons in the SCN exhibits 
a circadian rhythm that increases and peaks during the day and decreases at night. This 
oscillation in neuronal firing is one of the primary output signals from the SCN that 
coordinates the timing of behavior and physiology throughout the body (Colwell 2011). 
The rhythm of neuronal action potentials in the SCN is controlled by a feedback 
mechanism involving key clock genes known as the transcription/translation feedback 
loop (TTFL; Hastings et al 2008). The TTFL allows for synchronizing or entraining the 
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timing of endogenous rhythms to external environmental cues like light. In a properly 
functioning clock the internal rhythms, including the SCN neuronal activity rhythm, 
maintain synchrony with the external environment in a process known as entrainment. 
Entrainment ensures the correct timing of physiological processes like sleep, blood 
pressure, and feeding patterns (Saper et al 2005; Dominguez-Rodriguez et al 2010; 
Schibler et al 2003). Acute disruptions in clock function can occur when changing time 
zones or when working shift schedules. Continuous circadian disruptions over long 
periods can lead to problems such as metabolic syndrome and certain forms of cancer, 
and are even linked to Alzheimer’s disease (Maury et al 2010; Takahashi et al 2008; van 
Someran et al 1996).  
Anatomically the SCN is divided into two regions, the ventral core and dorsal shell. 
The ventral core receives glutamatergic inputs from the optic tract. The ventral core also 
receives neuropeptide Y and gamma aminobutyric acid (GABA) inputs from the 
intergeniculate leaflet and serotonergic and GABAergic inputs from the dorsal raphe 
nucleus (Moore and Silver 2008). The core then communicates these signals to the shell, 
however the circuitry involved in ventral to dorsal communication is still under 
investigation. After receiving inputs from the core, the dorsal shell sends circadian outputs 
mainly to the hypothalamus which then relays these signals to other brain regions 
(Abrahamson and Moore 2001).  
We and others have demonstrated that EtOH consumption can disrupt the SCN 
clock, including altering its endogenous period and inhibiting normal phase regulation 
(Brager et al 2010; Brager et al 2011; Ruby et al 2009; Rosenwasser et al 2005; McCulley 
et al 2013; Prosser et al 2003; McElroy et al 2009; Prosser and Glass 2009; Lindsay et al 
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2014). At least  some of these effects are due to actions specifically within the SCN, since 
EtOH applied to the SCN via microdialysis or applied in vitro inhibits phase resetting 
(Prosser 2003; Prosser et al 2008; Prosser and Glass 2009; Brager et al 2010; Ruby et 
al 2009). Conversely, other effects appear to involve actions outside the SCN (Pickard et 
al 1996; Graff et al 2006; Prosser et al 2008). The combined effects of EtOH on the 
circadian system impair proper adjustments to changes in environmental cycles, and 
could contribute to the circadian disruptions seen in alcoholics (Rouhani et al 1990; 
Rajakrishnan et al 1999; Kubota et al 2002; Rosenwasser et al 2005). This is supported 
by multiple reports showing disruptions in physiological rhythms in alcoholic patients 
(Adinoff et al 1991; Röjdmark et al 1993; Kühlwein et al 2003). Given that poor sleep 
quality is a common cause of relapse drinking (Gillin et al 1994; Brower, 2001; Brower 
2003) and disrupted circadian rhythms can contribute to impaired sleep (Dijk et al 2000; 
Crowley 2011; Ditisheim et al 2013), a better understanding of how EtOH affects the 
circadian clock is important.  
As mentioned above, the development of alcohol tolerance is one symptom of 
alcohol dependence. Many labs have investigated the mechanisms of tolerance in hopes 
of discovering effective treatments for, or ways to prevent, alcohol dependence. The most 
heavily studied forms of tolerance, known as acute, rapid, and chronic tolerance, differ 
with respect to how quickly they develop after initial alcohol consumption. In experiments 
using mammalian models, acute, rapid, and chronic tolerances develop within minutes, 
to hours, to days of alcohol consumption, respectively. The timing of these forms of 
tolerance is consistent with that seen in humans (Bierness and Vogel-Spott 1984; 
Hiltunen and Jarbe 1990; Bennett et al 1993). Experimentally, the different timing of 
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development for these forms of tolerance makes them easily distinguishable. Although 
the cellular mechanisms associated with these tolerance types are thought to differ 
(Khanna et al 1991a; Grobin et al., 1998; Roberto et al., 2006), there is little direct 
evidence of this based on within-experiment comparisons. Identifying differences in the 
mechanisms of tolerance could clarify the processes through which dependence to 
alcohol develops. 
Alcohol withdrawal-induced hyperexcitability is another characteristic of alcohol 
dependence. Research has shown that sudden abstinence after long-term EtOH use 
leads to a variety of changes in neuronal signaling that are distinct from those seen during 
tolerance. For instance, withdrawal from EtOH increases presynaptic glutamate release 
in many brain regions (Christian et al., 2013, Faingold et al., 2000, Kash et al., 
2009 and Roberto et al., 2004). Other studies have shown changes in pharmacological 
properties of GABA receptors following EtOH withdrawal (Veatch and Becker 2005; 
Kumar et al 2009; Linsenbardt & Boehm 2010). Although EtOH-induced changes in 
glutamate and GABA have been studied extensively using a wide variety of experimental 
paradigms, it is noteworthy that few studies have compared the changes in neuronal 
signaling associated with chronic EtOH exposure and EtOH withdrawal in a single 
experiment. 
Similar to other brain regions, we have shown that acute tolerance to EtOH 
inhibition of glutamate-induced phase resetting develops in the SCN in vitro (Prosser and 
Glass 2009). Conversely, evidence suggests that chronic tolerance to EtOH does not 
develop with respect to inhibition of in vivo photic phase resetting (Brager et al 2010). 
However, results from another study suggest that the lack of chronic tolerance seen in 
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those experiments may have been due to using forced EtOH consumption versus free-
choice EtOH drinking (Seggio et al 2009). With respect to the effects of EtOH withdrawal 
on circadian rhythms, enhanced photic phase shifts are seen during withdrawal in 
hamsters (Ruby et al, 2009), while EtOH withdrawal does not alter photic phase shifts in 
mice (Brager et al, 2010). On the other hand mice exhibit altered free-running circadian 
periodicity after withdrawal from 12 days of EtOH exposure (Logan et al 2012). In light of 
these variable results, we have investigated whether multiple forms of EtOH tolerance 
and withdrawal-induced glutamate sensitization occur in the SCN, using in vitro 
glutamate-induced circadian rhythm phase shifts as our primary experimental output. 
Moreover, we used multiple drinking paradigms to directly compare the different forms of 
EtOH-induced plasticity. At a functional level, we assessed changes in ionotropic 
glutamate (N-methyl-D-aspartate; NMDA) and GABA(A) receptor expression and 
phosphorylation in response to different EtOH consumption paradigms. 
Our approach is unique in that we are comparing the cellular changes that occur 
during rapid and chronic tolerance and during withdrawal-induced glutamate sensitization 
in a single model system. Our goals are two-fold: to clarify the cellular mechanisms 
through which EtOH affects the SCN circadian clock, and to better understand the cellular 
changes that occur during and after EtOH consumption. Given the epidemiological 
evidence linking alcohol tolerance and withdrawal symptoms to the development of 
alcohol abuse and relapse, the data from these experiments could be used to develop 
novel cellular targets for pharmacological intervention of AUD. 
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Circadian rhythms and the suprachiasmatic nucleus 
The transcriptional/translational feedback loop 
The circadian clock in the mammalian suprachiasmatic nucleus (SCN) 
synchronizes daily endogenous rhythms to external environmental cues. The mammalian 
circadian oscillator includes a transcriptional/translational feedback loop (TTFL) that 
functions over the 24 hour circadian day while maintaining synchrony with external timing 
cues (Figure 1.1a and b). At sunrise, the transcription factors CLOCK and Bmal1 dimerize 
and activate transcription of two families of genes, Period (Per) and Cryptochrome (Cry; 
Reppert and Weaver 2002). Per and Cry encode proteins that accumulate slowly over the 
course of the day (Figure 1.1a). As PER and CRY proteins accumulate, become 
phosphorylated, and dimerize, they enter the nucleus and negatively feedback onto 
CLOCK and Bmal1 to suppress transcription, with protein levels (and transcriptional 
inhibition) peaking near the middle of the night (Figure 1.1b). Over the remainder of the 
night, protein and mRNA levels decrease, allowing for another cycle of transcription to 
begin the next day (Reppert and Weaver 2002). Other genes such as Rev-erbα and 
RORα/β also coordinate the transcription of clock genes, particularly Bmal1. This cycling 
of transcriptional activation and inhibition maintains the timing of behaviors and 
physiological processes over 24 hours (h), and provides the mechanism through which 
the clock can respond to external timing cues.  
Photic phase shifts 
The phase of the circadian clock adjusts to changes in environmental cues, such 
as seasonal shifts in day length, or remaining active at irregular times, as well as daylight 
savings, travelling across time zones, and shift work (Stevens 2009; Kantermann et al 
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2007). The process through which circadian clocks adjust to timing stimuli is known as 
phase resetting. In mammals, photic phase shifts occur when light shines on the eyes at 
night and activates retinal ganglion cells. The signal propagates via the optic nerve to the 
SCN, causing glutamate to be released from retinal ganglion cells onto SCN neurons. 
The glutamate then binds to and activates NMDA receptors (Ding et al 1997; Mintz et al 
1999; Wang et al 2008), a critical step in the photic phase shifting process (Ebling 1996). 
Concurrent activation of the receptor tropomyosin receptor kinase B (TrkB) by brain-
derived neurotrophic factor (BDNF) is also necessary for phase shifts (Liang et al 1998; 
Liang et al 2000; Allen et al 2005; Kim et al 2006; Michel et al 2006; Mou et al 2009). This 
leads to TrkB autophosphorylation, which can activate kinases that phosphorylate NR2B 
subunits of NMDA receptors. The importance of activating NR2B-containing NMDA 
receptors for photic phase shifts was shown in experiments that blocked glutamate-
induced phase shifts with ifenprodil, an NR2B selective antagonist (Bendova et al 2012). 
Upon activation of NMDA and TrkB receptors, calcium ions (Ca2+) enter the cell, activating 
a variety of downstream signaling pathways. Eventually this leads to phosphorylation of 
the transcription factor cAMP response element binding protein (CREB), resulting in an 
increase in transcription of multiple genes, including the clock genes, Per1 and 2 
(Kornhauser et al 2002; Yokota et al 2001). Increased Per gene transcription will either 
phase delay or phase advance the clock (or have no effect) depending on the time of Per 
gene transcription (Shigeyoshi et al 1997; Yan et al 1999; Yan and Silver 2002). 
Therefore, the timing of the light-induced glutamate release in the SCN is paramount for 
determining whether it will induce a phase delay, a phase advance, or no shift. In vitro 
experiments investigating the cellular processes associated with photic phase shifts 
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typically bypass activation of retinal ganglion cells and directly apply glutamate onto SCN 
tissue (Ding et al 1997; Tischkau et al 2000; Prosser and Glass 2009; Lindsay et al 2014).  
 
Ethanol, ethanol tolerance, and their effects on glutamate and GABA signals 
Ethanol consumption paradigms 
EtOH research is challenging in part because EtOH has many targets. Acutely, 
EtOH affects extracellular proteins, receptor proteins, second messengers, transcription 
factors, and genetic regulators. However, it is well known that acute EtOH primarily 
inhibits glutamate signaling (Lovinger et al 1989) and enhances GABA signaling (Allan 
and Harris, 1986; Suzdak et al., 1986; Ticku et al., 1986). This is largely due to acute 
EtOH’s ability to modify glutamate receptor and GABA receptor function, decreasing 
cation flow through NMDA channels and increasing Cl- ion influx through GABA(A) 
channels (Roberto et al 2004; Proctor et al 2006; Moykkynen and Korpi 2012; Hughes et 
al 2013; Allan and Harris, 1986; Suzdak et al., 1986; Ticku et al., 1986; Wei et al 2004; 
Olsen et al 2007). This change in receptor activity by acute EtOH involves modulation of 
multiple receptor components including subunit expression, post-translational 
modification, and localization of receptors. Together, these acute effects of EtOH result 
in decreased neuronal activity, since glutamate generally increases neuronal activity and 
GABA inhibits neuronal activity (Crews et al 1996; Diamond and Gordon 1997). 
 A second complication is that the effects of EtOH can change over time due to the 
development of tolerance at cellular and physiological levels. While acute EtOH inhibits 
glutamate signaling, chronic ethanol leads to compensatory increases in glutamate 
release and/or receptor activation (Hendricson et al 2004; Roberto et al 2004; Clapp et al 
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2010; Wu et al 2010). Likewise, while acute EtOH enhances GABA(A) receptor signaling, 
chronic EtOH can decrease GABA signaling (Mihic and Harris, 1997; Kumar et al 2003; 
Liang et al 2007; Abramian et al 2010; Ron and Messing 2013). Compensatory changes 
in the brain in response to sustained EtOH exposure occur over varying time periods, 
leading to a variety of changes in receptor subunit composition, phosphorylation, and 
localization (Chandler et al 1998). These changes are believed to underlie the 
development of alcohol dependence and alcohol abuse. However, forcing animals to 
consume EtOH can generate distinct EtOH effects, as shown in multiple studies (Khanna 
1991a; 1993; Grover et al 1994; Ravindran et al 2007; Liang et al 2007; Pietrzykowsky 
and Triestman 2008; Prosser and Glass 2009; Seggio et al 2009; Gonzalez et al 2012; 
Lindemeyer et al 2014). Therefore, voluntary EtOH consumption may be preferable to 
forced EtOH exposure if one is trying to mimic the effects of alcohol consumption in 
humans. However, in experiments where animals control their level of EtOH consumption, 
it is important to monitor how much EtOH is consumed, and how much it varies across 
days/subjects. The EtOH consumption/exposure level is important because proteins have 
different levels of sensitivity to EtOH. For example GABA(A) receptors containing different 
subunits exhibit either low EtOH (>100mM) or high EtOH (<50mM) sensitivities (Wei et al 
2004; Santhakumar et al 2006; Wallner et al 2006). 
Finally, one also should consider the time of day the animals consume EtOH. Mice 
(and other nocturnal rodents) tend to drink the most during the early night (Brager et al 
2010 [mice]; Ruby et al 2009 [hamsters]; Rosenwasser et al 2014 [rats]). However, 
drinking in the morning vs evening can have distinct effects on EtOH induced behaviors 
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and cellular mechanisms (Deimling and Schnell 1980; Baird 1998; Damaggio and 
Gorman 2014).  
Based on these and other considerations, many different drinking paradigms have 
been utilized in the EtOH research field. For instance the chronic intermittent EtOH (CIE) 
paradigm involves switching between periods of EtOH consumption and periods of 
withdrawal in order to reliably escalate EtOH intake and overall blood alcohol 
concentration levels (Becker and Lopez 2004). For our experiments, we have used two 
paradigms: a single nighttime (12 h) of no-choice EtOH consumption to investigate rapid 
tolerance, and daily 4 h no-choice EtOH access (starting 1 h prior to lights-off, and 
continuing 3 h into the night) over different durations of drinking (7-21 days), followed by 
0-6 days of EtOH withdrawal. These drinking paradigms allow the mice to control the 
amount of EtOH they consume, and we have found that the inter- and intra-animal 
variability is low.  Using these protocols, we have investigated how EtOH affects NMDA 
and GABA receptors in the SCN. To put the experiments in context, background 
information on NMDA and GABA(A) receptors, how EtOH modifies their function, and 
their post-translational modifiers is presented here. 
NMDA Receptors 
Glutamate ionotropic NMDA receptors are heterotetromeric: they all contain two 
NR1 subunits plus two additional subunits, consisting of any combination of NR2A, NR2B, 
NR2C, NR2D, NR3A, and NR3B subunits. Upon activation, the ion channel opens, 
allowing Ca2+, sodium ions (Na+), and potassium ions (K+) to flow through the channel 
(Ca2+ and Na+ generally entering and K+ ions leaving the cell). This depolarizes the 
neuron, resulting in enhanced neuronal signaling. Each NMDA receptor subunit has 
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unique effects on NMDA receptor conductance characteristics. For example, an NR2A 
containing NMDA receptor has consistent and steady firing, whereas an NR2B containing 
NMDA receptor has more sporadic, burst firing with slower decay kinetics (Cull-Candy 
2004). NR2B-containing NMDA receptors remain open 10 times longer than NR2A-
containing NMDA receptors, thus allowing more depolarization and a greater increase in 
intracellular Ca2+ accumulation (Cull-Candy 2004). NMDA receptors containing both 
NR2A and NR2B subunits exhibit hybrid pharmacological and kinetic characteristics 
(Paoletti and Neyton 2007, Tovar et al 2013). NMDA receptors containing NR3 subunits 
are inactive. While the type of subunits defines the overall characteristics of the NMDA 
receptor, the receptor kinetics can also be altered via post-translational modifications.  
One key post-translational modification of NMDA receptors is phosphorylation. 
Phosphorylation of specific NMDA receptor subunit residues can alter ion movement in 
and out of the channel or change the localization of the receptor. For example 
phosphorylation of NR2B tyrosine 1472 (Y1472) increases Ca2+ ion influx through the 
NMDA receptor (Nakazawa et al 2001) and maintains its localization within the synaptic 
active zone (Goebel et al 2005). This is due to phosphorylated Y1472 enhancing NR2B 
binding with a scaffolding protein, post-synaptic density-95 (PSD-95; Roche et al 2001; 
Prybylowski et al 2005; Zhang et al 2008). Upon phosphorylation of Y1472 by Fyn kinase 
(Fyn; Trepanier et al 2012; Gibb et al 2011), the C-terminus of the NR2B subunit binds to 
the PSD-95/Discs large/zona occludens-1 (PDZ) binding domain of PSD-95.  
On the other hand, phosphorylation of serine 1480 (S1480) breaks the interaction 
of the NR2B subunit with PSD-95. This leads to internalization of the NMDA receptor 
followed by the receptor either recycling back to the surface or being targeted for 
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degradation via ubiquitination (Roche et al 2001; Chung et al 2004). Phosphorylation of 
S1480 involves calcium/calmodulin dependent protein kinase II (CaMKII) forming a 
complex with the constitutively active kinase, casein kinase 2 (CK2), to form a tri-
molecular complex with NR2B. This localizes CK2 to the S1480 residue, increasing CK2 
phosphorylation of S1480 (Sanz-Clemente et al 2013).  
EtOH and NMDA Receptors  
Many studies have demonstrated that the EtOH-induced modulation of NMDA 
receptors involve changes in the phosphorylation of Y1472 and S1480 of the NR2B 
subunit, suggesting that this subunit is highly sensitive to the effects of EtOH (Chandler 
et al 1998; Wang et al 2010; Wu et al 2010; Clapp et al 2010, Staples et al 2015). 
However, there are other aspects of NMDA receptors that are affected by EtOH, and 
these effects vary depending on the duration of EtOH exposure. For example, acute EtOH 
inhibits NMDA receptor conductance (Roberto et al 2004), while chronic EtOH increases 
NMDA signaling (Kroener et al 2012) and alters subunit composition of NMDA receptors, 
with many brain regions exhibiting increases in NR2A, NR2B, and NR1 subunit 
expression (Clapp et al 2010; Pian et al 2010; Wu et al 2010; Wang et al 2011; Staples 
et al 2015). Even though the expression of most NMDA receptor subunits is increased 
during chronic EtOH exposure, some studies suggest EtOH has preferential effects for 
the NR2B subunit. For example, in the hippocampus, a 15 minute (min) exposure to 
100mM EtOH induces H-ras mediated endocytosis of NR2A subunits and increases the 
ratio of NR2B to NR2A subunit containing NMDA receptors (Suvarna et al 2005). Also, 
transgenic mice with a conditional knockout of the NR2B subunit do not develop 
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enhanced neuronal firing in response to chronic EtOH application to the bed nucleus of 
the stria terminalis (Wills et al 2012).  
Ethanol and post-translational modifiers of NMDA receptors 
EtOH alters the posttranslational modifications of NMDA receptors largely by 
altering the activity of kinases and phosphatases that target key residues of NMDA 
receptors (Barria and Malinow 2005; Prybylowski et al 2005; Honse et al 2003; Suvarna 
et al 2005). Acute vs. chronic EtOH appears to have differential effects on kinases that 
phosphorylate NMDA receptors (Xu et al 2006; Kash et al 2009; Chung et al 2004). 
Unfortunately, direct comparisons are difficult because few studies have compared EtOH 
modulation of these proteins across multiple EtOH exposure paradigms. With this caveat 
in mind, in this section we focus mainly on EtOH’s modulation of Fyn kinase, CaMKII, and 
striatal enriched tyrosine receptor phosphatase-61 (STEP-61). 
Fyn phosphorylates Y1472 of the NMDA receptor NR2B subunit. Before this can 
occur, Fyn must be phosphorylated at its tyrosine 420 (Y420) residue in response to 
mature BDNF activating TrkB (Yamada and Nabeshima 2004; Carreño et al 2011). 
Neuronal cell adhesion molecule-1 (NCAM-1), a neuronal cell adhesion molecule that 
regulates synaptogenesis, can also activate Fyn via interactions with receptor-like protein 
tyrosine phosphatase α (RPTPα, Bodrikov et al 2005). Acute and chronic exposure to 
EtOH do not alter total Fyn protein expression in the hippocampus and striatum (Wu et al 
2010; Darcq et al 2014), but chronic EtOH increases Y420 phosphorylation through 
inactivation of STEP-61 in the dorsal medial striatum (Darcq et al 2014). EtOH can alter 
expression of BDNF and TrkB, but the effects are regionally specific, with some regions 
exhibiting increases in BDNF and TrkB while others have decreases (Davis 2008). 
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Chronic EtOH also decreases polysialic acid (PSA) containing NCAM-1, which allows for 
Fyn activation due to PSA blocking NCAM-1 related cell signals (Barker et al 2012).  
CaMKIIα, another kinase important for NMDA receptor regulation, forms a complex 
with CK2, allowing for increased phosphorylation of NR2B serine 1480 (S1480). 
Activation of CaMKII involves increases in calcium influx, causing autophosphorylation of 
CaMKIIα at threonine 286 (T286) (Davies et al 2007). This also causes 
autophosphorylation of threonine 305 (T305), which reduces activation of CaMKIIα 
(Colbran 1993; Zhang et al 2005). A recent study has demonstrated that phosphorylation 
of CaMKIIα at T286 is associated with acute EtOH-induced increases in c-fos expression, 
suggesting CaMKIIα activation is important for EtOH-related increases in neuronal firing 
(Schöpf et al 2015). Also chronic ethanol increases T286 phosphorylation, but no 
changes were noted in CaMKII expression in the amygdala during chronic EtOH or EtOH 
withdrawal (Christian et al 2012). Because CaMKIIα activation via T286 phosphorylation 
correlates with increases in neuronal activity in the SCN (Kon et al 2014) and many other 
regions, EtOH-induced changes in CaMKIIα T286 phosphorylation could underlie some 
of its actions on the SCN circadian clock. 
STEP-61 decreases phosphorylation of NR2B Y1472. This reduces activation of 
the NMDA receptor and ultimately leads to receptor internalization. Recent studies have 
shown that proteosomal degradation of STEP-61 occurs through PSD-95 and BDNF, 
which target STEP-61 for ubiquitin induced degradation (Won et al 2016; Saavedra et al 
2016). Protein kinase A (PKA) also blocks STEP-61 from interacting with its substrates 
by phosphorylating its serine 221 (S221) residue (Paul et al 2000). Studies have 
demonstrated that chronic EtOH does not alter total STEP-61 expression, but does 
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increase phosphorylation at the serine 221 residue, again reducing STEP-61 
dephosphorylation of NMDA receptors (Darcq et al 2014). Thus, chronic EtOH could 
increase NMDA receptor activity in part by decreasing activation of STEP-61. 
GABA receptors 
As mentioned earlier, many actions of EtOH involve changes in GABA related 
signals. GABA(A) receptors are pentameric with multiple combinations of receptor subunit 
types generating up to 19 different GABA(A) receptor isoforms. The most common 
receptor isoforms include 2 α subunits, 2 β subunits, and either a γ or δ subunit (Olsen 
and Sieghart 2008). The α and β subunits are important for regulating ion channel 
conductance properties, while the γ and δ subunits regulate the localization of GABA 
receptors in and out of the synaptic active zone. Activation of GABA(A) receptors that 
contain γ subunits, which are typically localized within the synapse, causes phasic 
inhibitory currents in neurons (Farrant and Nusser 2005), while δ subunit-containing 
GABA(A) receptors, which generate tonic inhibitory currents, are typically found in 
extrasynaptic regions. Another important distinction is that δ subunit-containing GABA(A) 
receptors have a much higher sensitivity to EtOH than γ subunit-containing GABA(A) 
receptors (Wei et al 2004; Santhakumar et al 2006; Wallner et al 2006). Because 
activating GABA(A) receptors increases Cl- conductance, GABA signaling is generally 
inhibitory, decreasing the signaling of its post-synaptic targets.  
Regulation of GABA(A) receptors, like NMDA receptors, occurs through a series 
of post-translational modifications to key residues. The PKA and protein kinase C (PKC) 
kinases are well documented regulators of GABA(A) receptors via phosphorylation of 
specific residues, particularly on the α4 subunit. By phosphorylating serine 408 and serine 
17  
409 of the GABA(A) β3 subunit, PKA decreases synaptic α4 synaptic expression but 
increases extrasynaptic α4 expression (Bohnsack et al 2016). Conversely, PKCγ 
increases synaptic α4 expression via phosphorylation of the serine 443 residue 
(Abramian et al 2010). PKC can also stimulate internalization of α4 containing GABA(A) 
receptors by phosphorylating the β2 subunit (Bright and Smart 2013). Thus regulation of 
GABA(A) receptor function occurs via modulation of posttranslational modifiers leading 
to changes in channel flux, localization to the synaptic or extrasynaptic regions, and 
subunit composition of the receptor. 
EtOH and GABA receptors  
EtOH alters GABA signaling, and its actions at GABA(A) receptors differ 
depending on the duration of EtOH exposure in the same manner as seen with NMDA 
receptors. Acute EtOH’s actions on GABA(A) receptors are subunit specific. For example, 
EtOH enhances influx of Cl- ions through γ subunit-containing GABA(A) receptors (Allan 
and Harris, 1986; Suzdak et al., 1986; Ticku et al., 1986; Wei et al 2004; Olsen et al 2007) 
while decreasing tonic currents mediated by δ subunit-containing GABA(A) receptors 
(Liang et al 2007). The effects of chronic EtOH compared to acute EtOH on GABA(A) 
receptors are more complex. For instance chronic EtOH reduces the expression of 
particular GABA(A) subunits, alters their phosphorylation, and leads to internalization of 
GABA(A) subunits, particularly those receptors containing α1, β1, and γ subunits (Kumar 
et al 2003; Liang et al 2007; Abramian et al 2010; Ron and Messing 2013). In contrast, 
chronic EtOH lasting at least 40 days of exposure increases α4 and δ subunit mRNA 
expression in the hippocampus (Matthews et al 1998; Cagetti et al 2004). In short, acute 
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EtOH enhances actions of γ containing and inhibits δ containing GABA(A) receptors, 
while chronic EtOH inhibits γ containing and enhances δ containing GABA(A) receptors. 
EtOH and post translational modifiers of GABA(A) receptors 
Acute and chronic EtOH can also modify the function of kinases that phosphorylate 
GABA(A) receptor subunits. Acute EtOH-induced changes in kinase activity alters 
receptor activation and membrane localization (Brandon et al 2000; Brandon et al 2003; 
Carlson et al 2013; Carlson et al 2014; Choi et al 2008; Kumar et al 2010). The PKC 
family of kinases in particular are implicated in EtOH effects on GABA(A) receptors 
(Wallace et al 2006; Bowers et al 1999). PKCγ is required for ethanol induced increases 
in the surface localization of α4 subunits in cerebral cortical neurons, but the specific 
mechanism of interaction through which PKCγ affects GABA(A) α4 subunits is still 
unknown (Werner et al 2011). Recent research has suggested chronic EtOH influences 
PKCγ phosphorylation of α4 subunit serine 443, increasing α4 subunit surface localization 
(Werner et al 2016 referring to Abramian et al 2010). Thus acute and chronic EtOH 
induced modulation of GABA(A) receptors may involve modulation at the α4 subunit via 
EtOH’s actions on PKCγ.  
Other studies have suggested that EtOH alters regulation of GABA(A) α4 subunits 
by PKA and not PKC. Support for this comes from studies showing that acute EtOH 
activates both PKA and PKC (Dohrman et al 1996; Messing et al 1991). Further support 
for this comes from studies confirming acute EtOH induced modulation of α4 trafficking 
after concurrent activation of PKC and PKA (Kumar et al 2012; Carlson et al 2013). 
Furthermore, a recent study has shown that direct activation of PKA and not PKC 
increases the surface localization and tonic current of α4/δ GABA(A) receptors, while 4 h 
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of ethanol exposure reduces α4/δ receptor abundance (Carlson et al 2016). Thus EtOH 
appears to modulate localization of α4/δ GABA(A) receptors through multiple 
mechanisms.  
It is possible that the mixed results on PKA and PKC modulation of α4/δ GABA(A) 
receptors are due to different durations of EtOH exposure, with acute EtOH mediating the 
effects of α4/δ via PKA (evident by Carlson et al 2016) and chronic EtOH mediating the 
effects of α4/δ via PKC (evident by Werner et al 2016). As indicated earlier, acute vs 
chronic EtOH exposure differentially regulates receptor currents and subunit composition, 
and can also differentially affect kinases and phosphatases. Therefore, investigating 
changes in PKA and PKC associated with different forms of EtOH tolerance may be 
worthwhile.  
EtOH tolerance 
EtOH tolerance is defined as requiring higher concentrations of EtOH to achieve 
the same effect. Tolerance includes changes at the behavioral level, termed behavioral 
tolerance, as well as cellular changes, termed physiological tolerance (Chandler et al 
1998). Behavioral tolerance to EtOH involves the effects of EtOH across many brain 
regions, as demonstrated in experiments assessing whether behavioral modifications 
normally induced by EtOH (e.g. loss of coordination) are changed after continued EtOH 
exposure (Grieve and Littleton 1979; Pietrzykowsky and Triestman 2008). Physiological 
tolerance typically refers to the effects of EtOH tolerance on peripheral mechanisms (e.g., 
metabolism) and/or how cellular/molecular components of neurons in specific brain 
regions are modified during continued exposure. Physiological and behavioral EtOH 
tolerance develops over multiple time domains in mammals, including minutes (acute 
20  
tolerance), hours (rapid tolerance), and days (chronic tolerance). Acute tolerance has 
been shown to involve changes in NMDA receptor and GABA(A) receptor related 
currents. For example, while initial exposure of CA1 hippocampal tissue to EtOH reduces 
isolated field potentials from NMDA receptors, this effect decreases with continued 
exposure over 15 minutes (Grover et al 1994). Also EtOH potentiation of GABA(A) 
currents diminishes after 5-60 minutes of EtOH exposure in  cell cultures prepared from 
the cerebellum (Allan and Harris 1987).  
Rapid tolerance, the least studied of the three forms, has been proposed to 
underlie the transition from acute to chronic tolerance (Khanna et al 1991a). Most 
experiments have focused on the involvement of NMDA and GABA(A) receptors in 
behavioral rapid tolerance and have not addressed physiological rapid tolerance. 
Pharmacologically, blocking NMDA receptors with the selective antagonist, MK-801, 
blocks behavioral rapid tolerance to EtOH (Khanna et al 1991b; 1993). Muscimol, a 
GABA(A) agonist, also blocks behavioral rapid tolerance to EtOH (Barbosa and Morato 
2001). Unfortunately, literature investigating the cellular effects underlying physiological 
rapid tolerance to EtOH is sparse.  
Many studies have demonstrated changes to NMDA and GABA(A) currents during 
chronic tolerance to alcohol. As mentioned, changes in expression and phosphorylation 
of NMDA receptors and GABA receptors have been reported in chronic tolerance and 
chronic EtOH (Wu et al 2010; Kroener et al, 2012; Honse et al 2003; Suvarna et al 2005; 
Wang et al 2011; Ravindran et al 2007, Liang et al 2007, Gonzalez et al 2012, Lindemeyer 
et al 2014). Chronic treatments of EtOH also cause behavioral tolerance with respect to 
cognitive impairment and to the sedative effects of EtOH (Rafi-Tari et al 1996; Wu et al 
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2010). Similarly, chronic tolerance has been demonstrated with respect to circadian 
periodicity and locomotor activity in mice with respect to circadian regulated behaviors 
(Logan et al 2012). Differences regarding cellular changes in chronic tolerance versus 
other tolerance types are distinct given the changes that occur to subunit expression and 
phosphorylation.  
Ethanol withdrawal 
The sudden withdrawal from EtOH after sustained EtOH exposure induces drastic 
changes in behavior and physiology that can lead to symptoms like insomnia, 
psychomotor agitation, hallucination, and delirium tremens (Schuckit 2014). 
Experimentally in animals, the effects of EtOH withdrawal are typically studied during the 
first 1-2 days, which corresponds to when the more intense behavioral and physiological 
effects of EtOH withdrawal occur (Schuckit 2015). This is not to suggest that the effects 
of withdrawal last only during this timeframe. Some studies have used longer periods of 
EtOH abstinence that can extend from one week to several weeks. These studies are 
often performed to determine the duration of EtOH withdrawal induced effects as well as 
investigate novel effects across longer durations of withdrawal. For example Ding et al 
2013 determined that the increased presynaptic glutamate release that develops during 
EtOH exposure lasts 7 days after withdrawal.  
Studies have demonstrated that EtOH withdrawal is associated with increases in 
extracellular glutamate in various brain regions (Ding et al 2013; Griffin et al 2014). Some 
have suggested this is due to increased presynaptic release of glutamate that develops 
during chronic EtOH exposure (Roberto et al 2004; Christian et al 2013). Additionally, 
physiological and behavioral changes exhibited during EtOH withdrawal are blocked by 
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glutamate receptor antagonists, suggesting increased activation of glutamate receptors 
occurs during EtOH withdrawal (Faingold et al 2000; Farook et al 2008). The overt effects 
of sudden abstinence from EtOH are likely due in part to the inability of glutamate signals 
to immediately revert to pre-EtOH exposure levels following withdrawal.  
The effects of EtOH withdrawal also involve GABA receptors. Changes seen 
during withdrawal include increases in GABA(A) receptor expression in the nucleus 
accumbens (Linsenbardt & Boehm 2010). A study investigating the basolateral amygdala 
demonstrated that surface expression of the α4 and γ2 subunits increase after 2 days of 
withdrawal following chronic intermittent ethanol, while expression of α1, α2, and δ 
subunits decrease (Lindmeyer et al 2014). Also, the GABA(A) agonist lorazepam reduces 
handling-induced convulsions that occur after repeated EtOH withdrawals, suggesting 
that enhancing GABA(A) activity during EtOH withdrawal can diminish withdrawal related 
pathologies (Veatch and Becker 2005). Thus GABA(A) receptors are a strong candidate 
for investigating and comparing changes in tolerance and withdrawal to EtOH. 
 
Studying ethanol tolerance and withdrawal-induced sensitization in the SCN 
circadian clock 
Ethanol disrupts circadian clock function 
Because circadian rhythms regulate sleep, and alcohol disrupts sleep, we and 
others hypothesized that alcohol-induced disruptions in sleep are at least partially due to 
disturbances in circadian regulation (Brower 2001; Prosser et al 2003; Åkerstedt 2003; 
Chokroverty 2010; Rosenwasser 2010). Because persistent sleep problems after EtOH 
withdrawal are a strong predictor of relapse drinking (Brower and Perron 2010; Hasler et 
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al 2010), a better understanding of how EtOH affects sleep could lead to improved 
treatment for AUD. Over the past 15 years substantial evidence has accumulated 
showing that EtOH affects circadian rhythms and, conversely, that the circadian clock 
affects EtOH consumption. 
Ethanol disrupts many aspects of circadian regulation. For instance, EtOH alters 
mRNA levels of the core clock genes Period1, Period2, and Period3 (Per1, Per2, and 
Per3) in adolescent and adult rats (Chen et al 2004; 2006). On the other hand, mutation 
of core clock genes contributes to AUD, EtOH abuse, and relapse. Mutating the Per2 
gene in mice reduces expression of the glutamate transporter, Eaat1, leading to 
increased extracellular glutamate and increased EtOH consumption (Spanagel et al 
2005a). Another study demonstrated that both Per1 and Per2 mutant mice have 
increased drinking and alcohol seeking behaviors (Gamsby et al 2013). In the same 
study, Per1 mutants had higher blood alcohol levels than controls 1 h after a single 
administration of EtOH, suggesting altering clock genes disrupts EtOH metabolism 
(Gamsby et al 2013). Mice selectively bred for high or low EtOH consumption also have 
modified core clock gene mRNA expression (Rosenwasser et al 2005; McCulley et al 
2013). Thus clock genes have a role in EtOH consumption and EtOH metabolism, while 
EtOH disrupts clock gene expression. 
Human studies have demonstrated more links between circadian disruptions and 
EtOH. Patients with AUD have a high prevalence of depression. Treating circadian 
disruption with anti-depressants can reverse circadian abnormalities (Duncan 1996), 
suggesting AUD and circadian disorders involve disruptions to similar neuronal circuits. 
Abstinent alcoholics have disruptions of circadian patterning, in that activity patterns tend 
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to be disorganized with greater effects seen in more severe cases of EtOH withdrawal 
(Sano et al 1994). Studies assessing mRNA levels of clock genes (Clock1, Bmal1, Per1, 
Per2, Cry1, and Cry2) from peripheral blood mononuclear cells from AUD patients 
revealed decreased mRNA expression of all of these genes compared to controls (Huang 
et al 2010). Mutations in the CLOCK and Per2 genes in humans are also linked to 
alcoholism (Spanagel et al 2005b; Sjoholm et al 2010). Studies assessing the effects of 
AUD on free-running rhythms and phase resetting in humans, however, have not been 
conducted. Thus researchers have turned to animal models to investigate these effects. 
Many studies have demonstrated EtOH modulation of free-running clocks and 
phase resetting in animal models. For instance EtOH consumption disrupts SCN 
circadian clock free-running period and phase resetting in rodents (Lindsay et al 2014 
Brager et al 2010; Ruby et al 2009; Seggio et al 2009; Rosenwasser et al 2005). Research 
with Drosophila melanogaster yields similar results with respect to EtOH induced 
disruptions in clock periodicity (Seggio et al 2012; Ahmad et al 2013). Other rodent studies 
have shown that drinking during the night versus during the day can increase EtOH 
withdrawal induced fatality incidences, alter body temperature, and reduce activity, 
suggesting that the timing of EtOH consumption has differing effects on the SCN 
(Damaggio and Gorman 2014; Deimling and Schnell 1980; Baird 1998). With respect to 
phase resetting, our in vitro experiments in mice show direct actions of EtOH within the 
SCN, including EtOH inhibition of glutamate phase resetting, enhancement of 
serotonergic phase resetting, and involvement of both TrkB and δ-subunit containing 
GABA(A) receptors in these effects (Prosser et al 2008; Brager et al 2011; McElroy et al 
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2009). Although these studies demonstrate acute EtOH actions in the SCN, a critical 
characteristic of AUD is the development of tolerance. 
In the SCN, tolerance is evident as decreased EtOH inhibition of photic/glutamate 
phase shifts (Prosser and Glass 2009; Lindsay et al 2014; Brager et al 2010). The SCN 
exhibits all three forms of tolerance: acute, rapid, and chronic, as well as withdrawal-
associated glutamate hypersensitivity as indicated in this research (Prosser and Glass 
2009; Lindsay et al 2014a; Lindsay et al 2014b; Lindsay et al 2014c). However, the distinct 
cellular mechanisms underlying each of these conditions are not known. In our studies 
we have determined how long it takes for rapid vs. chronic tolerance and withdrawal to 
develop, and have identified distinct changes in NMDA subunit and GABA(A) subunit 
expression, phosphorylation, and surface expression that occur during EtOH tolerance 
and withdrawal hypersensitivity. We choose to focus on effects on NMDA and GABA(A) 
receptors due to the fact that these receptors are key targets of EtOH and they are key 
regulators of SCN circadian clock functioning. From this, we hope to gain a better 
understanding of the mechanisms associated with each form of EtOH tolerance so that 
we may identify key alterations in neuronal function that are necessary for each individual 
tolerance mechanism.  
In our experimental model we assess cellular changes across EtOH tolerance and 
withdrawal hypersensitization and focus particularly on differences in the developmental 
timing of EtOH tolerance and withdrawal induced sensitization. Moreover, our 
assessments are conducted at key time points across the day [Zeitgeber time (ZT) 6, 
ZT16, and ZT23; Zetigeber time is based on the light-dark cycle, with ZT0 being lights-on 
and ZT12 being lights-off in the animal colony.] when baseline neuronal activity differs in 
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the SCN and when glutamate has distinct effects. At ZT 6, when neuronal activity is 
highest, glutamate does not modulate clock phase. At ZT 16, when neuronal activity is 
nearing its trough, glutamate delays clock phase. AT ZT 23, when neuronal activity is 
starting to rise, glutamate phase-advances the SCN clock. Using the SCN, we 1) 
investigate EtOH tolerance and withdrawal physiologically via assessing glutamate-
induced phase resetting; 2) assess changes in receptors and their key regulators across 
these different states; and 3) compare differences in these EtOH consumption-induced 
changes across distinct baseline cellular states within a single brain area. We 
hypothesized that EtOH tolerance and withdrawal induced sensitization are associated 
with changes in the expression and phosphorylation state of NR2B containing NMDA 
receptors in the SCN, and that the extent that these changes occur differs across the 
tolerance and withdrawal paradigms.  
 
Summary of introduction 
The expression of EtOH tolerance and withdrawal symptoms are two criteria for the 
diagnosis of an AUD. The cellular mechanisms associated with EtOH tolerance and 
withdrawal hypersensitivity are not well understood. Furthermore, little if any research has 
attempted to compare cellular changes associated with different durations of EtOH use 
and withdrawal. We use the SCN, the locus of the primary circadian oscillator, to study 
different types of tolerance using glutamate induced phase shifts as our experimental 
output. This model was chosen because photic phase shifts depend upon NMDA 
receptors and are modulated by GABA(A) receptor activation (Mintz et al 1999; Ralph 
and Menaker 1989; Gillespie et al. 1997; Herzog et al 2017), and EtOH modifies these 
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receptors as well as the kinases and phosphatases that regulate their function. Thus 
using glutamatergic phase shifts as an experimental output should constitute an excellent 
indicator of changes in neuronal physiology due to EtOH tolerance and EtOH withdrawal. 
We also investigate the changes that occur with respect to NMDA receptor subunit 
expression, phosphorylation, and localization by comparing tolerance and withdrawal 
induced sensitization in a single experiment. We planned to perform similar experiments 
investigating GABA(A) receptors, but were unable due to time constraints. The literature 
demonstrates that there are changes associated with acute and chronic EtOH. However, 
there is little known about how these receptors mediate tolerance, and how their 
regulation is variably altered by different forms of tolerance and withdrawal induced 
sensitization. Thus, we will investigate different forms of tolerance and withdrawal 
sensitization to EtOH in the SCN via photic phase shifts, and assess which cellular 
mechanisms associated with different forms of tolerance and withdrawal induced 
sensitization are distinct.  
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Figure 1.1 The transcription translation feedback loop (TTFL) maintains the timing of 
circadian rhythms in the majority of mammalian cells. (A) At the beginning of the day 
CLOCK and Bmal1 heterodimerize and translocate into the nucleus of the cell. This 
complex activates transcription of many genes including period (Per) and cryptochrome 
(Cry). As the day progresses, Per and Cry mRNA become translated into proteins. Once 
the PER and CRY proteins become phosphorylated, PER and CRY heterodimerize and 
translocate to the nucleus. The PER:CRY complex then inhibits function of CLOCK and 
Bmal1. (B) As the day ends and night begins, the transcriptional activation by 
CLOCK:Bmal1 is greatly reduced by the feedback inhibition of PER:CRY. Because of 
this, protein and mRNA levels decrease over the remainder of the night, which decreases 
the inhibitory feedback, allowing for another cycle of transcription to begin the next day 
(blue arrows). 
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Chapter 2 
The Mammalian Circadian Clock in the Suprachiasmatic Nucleus Exhibits Rapid 
Tolerance to Ethanol In Vivo and In Vitro 
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This chapter is adapted for dissertation formatting from the following publication: 
Lindsay, J. H., J. D. Glass, M. Amicarelli, and R. A. Prosser (2014). The mammalian 
circadian clockin the suprachiasmatic nucleus exhibits rapid tolerance to ethanol in vivo 
and in vitro. Alcoholism, Clinical and Experimental Research 38 (3), 760-769. 
My primary contributions to this paper were in the following areas (excluding in vivo data 
that was provided by members of Dr. Glass’ research team): designing the experiments, 
performing experimental procedures, collecting and analyzing data, interpreting data, 
preparing the figures and writing the manuscript. 
 
Abstract 
Background 
Ethanol (EtOH) triggers cellular adaptations that induce tolerance in many brain 
areas, including the suprachiasmatic nucleus (SCN), the site of the master circadian 
clock. EtOH inhibits light-induced phase shifts in the SCN in vivo and glutamate-induced 
phase shifts in vitro. The in vitro phase shifts develop acute tolerance to EtOH, occurring 
within minutes of initial exposure, while the in vivo phase shifts exhibit no evidence of 
chronic tolerance. An intermediate form, rapid tolerance, is not well studied but may 
predict subsequent chronic tolerance. Here, we investigated rapid tolerance in the SCN 
clock. 
Methods 
Adult C57BL/6 mice were provided 15% EtOH or water for one 12-hour lights-off 
period. For in vitro experiments, SCN-containing brain slices were prepared in the 
morning and treated for 10 minutes with glutamate +/− EtOH the following night. Single-
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cell neuronal firing rates were recorded extracellularly during the subsequent day to 
determine SCN clock phase. For in vivo experiments, mice receiving EtOH 24 hours 
previously were exposed to a 30-minute light pulse immediately preceded by 
intraperitoneal saline or 2 g/kg EtOH injection. Mice were then placed in constant 
darkness and their phase-shifting responses measured. 
Results 
In vitro, the SCN clock from EtOH-exposed mice exhibited rapid tolerance, with a 
10-fold increase in EtOH needed to inhibit glutamate-induced phase shifts. Co-application 
of brain-derived neurotrophic factor prevented EtOH inhibition, consistent with 
experiments using EtOH-naïve mice. Rapid tolerance lasts 48 to 96 hours, depending on 
whether assessing in vitro phase advances or phase delays. Similarly, in vivo, prior EtOH 
consumption prevented EtOH's acute blockade of photic phase delays. Finally, 
immunoblot experiments showed no changes in SCN glutamate receptor subunit (NR2B) 
expression or phosphorylation in response to rapid tolerance induction. 
Conclusions 
The SCN circadian clock develops rapid tolerance to EtOH as assessed both in 
vivo and in vitro, and the tolerance lasts for several days. These data demonstrate the 
utility of the circadian system as a model for investigating cellular mechanisms through 
which EtOH acts in the brain. 
 
Introduction 
Alcohol abuse is a debilitating condition linked to depression, sleep disorders, and 
cognitive defects (Brower 2001; Hesselbrock 1991; Sullivan and Pfefferbaum 2005). 
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Neurochemically, alcohol affects multiple neurotransmitter systems, including GABA and 
glutamate signaling (Ariwodola and Weiner 2004; Carta et al 2003; Hanchar et al 2005; 
Wu et al 2010; Zhu and Lovinger 2006). However, ethanol's (EtOH's) effects can exhibit 
tolerance, or desensitization, as assessed behaviorally (e.g., ataxia and hypothermia; 
Crabbe et al 1979; Gill and Deitrich 1998) and electrophysiologically (Knott et al 2002). 
For example, acute tolerance occurs within minutes of exposure to EtOH, while chronic 
tolerance to EtOH develops over weeks to months (Khanna et al 1991). Not surprisingly, 
the cellular mechanisms underlying these 2 forms of tolerance appear to be different 
(Grobin et al 1998; Roberto et al 2006). 
Intermediate to these is rapid tolerance, a less-studied phenomenon that develops 8 to 
24 hours after initial exposure to EtOH. This form of tolerance is seen with hypnotic, 
motor, and hypothermic effects of EtOH (Gilliam 1989; Silveri and Spear 1999). While 
rapid tolerance may be a predictor of subsequent chronic tolerance development (Khanna 
et al 1991; Radcliffe et al 2006; Wu et al 2001), little is known about its prevalence or 
cellular basis. 
The suprachiasmatic nucleus (SCN) circadian clock is the master 24-hour 
oscillator that regulates daily behavioral and physiological rhythms in mammals. External 
cues, particularly light, synchronize the SCN clock to the cyclic environment. Disruptions 
in clock synchronization are linked to diverse clinical conditions, including sleep disorders, 
diabetes, and cancer (Blask et al 2003; Crowley 2011; Dauchy et al 1999; Dijk et al 2000; 
Stevens 2006). As alcohol abuse is associated with chronic sleep problems and other 
pathologies (Åkerstedt 2003; Anstey et al 2009; Brower 2001; Grewal and 
Viswanathen 2012; Riley et al 2011), it is important to understand the neurophysiological 
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mechanisms through which EtOH affects circadian clock phase regulation. In this regard, 
we and others have shown that EtOH disrupts circadian rhythms through actions within 
and outside the SCN (Prosser and Glass 2009; Rosenwasser et al 2005; Spanagel 
et al 2005). For example, acute EtOH administered peripherally or via microdialysis into 
the SCN inhibits photic phase shifts in vivo (Brager et al 2011), while EtOH applied to the 
SCN in vitro inhibits glutamate-induced phase resetting (Prosser et al 2008). Likewise, 
chronic EtOH consumption inhibits photic phase shifts in vivo (Brager et al 2010). 
Interestingly, the similar inhibition of SCN photic phase resetting seen with both 
acute and chronic EtOH in vivo suggests that the circadian system does not develop 
chronic tolerance to EtOH. This contrasts with our findings regarding acute tolerance in 
vitro: the SCN develops acute tolerance within 5 to 15 minutes of initial EtOH exposure, 
as exhibited by a loss of EtOH inhibition of glutamatergic phase resetting (Prosser and 
Glass 2009). To further explore EtOH tolerance within the SCN and better understand the 
differences between the in vivo and in vitro conditions, we investigated rapid tolerance to 
EtOH using both in vivo and in vitro approaches in the mouse. 
 
Materials and methods 
Animals 
Adult (~8 weeks old) male C57BL/6 mice were obtained from Harlan Laboratories 
(Frederick, MD) and Jackson Laboratories (Bar Harbor, ME). Animals were singly housed 
in polycarbonate cages under a 12:12 light/dark (LD) cycle at a light intensity of 270 lux, 
in a temperature-controlled vivarium (23°C) with food and water provided ad libitum. The 
experiments followed the National Institutes of Health Guidelines for the Care and Use of 
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Laboratory Animals and were approved by the University of Tennessee Institutional 
Animal Care and Use Committee and Kent State University Institutional Animal Care and 
Use Committee. 
EtOH consumption 
Mice were trained to drink water from drip-resistant sipping tubes (Medical 
Associates, Inc., St. Albans, VT) for 2 days prior to introducing EtOH. On the first day of 
the experiment, the water bottle of each “EtOH-exposed” mouse was replaced with one 
containing 15% EtOH immediately prior to lights-off. Mice were then allowed to consume 
alcohol overnight. Control (“EtOH-naïve”) mice had their water bottles replaced with ones 
containing water. Although we did not monitor the pattern of EtOH/water consumption, 
our previous studies indicate that mice do the majority of their drinking (EtOH and/or 
water) in the first half of the night (Brager et al 2010). The following morning at lights-on, 
the amount of EtOH (or water) consumed overnight was measured, and the animals were 
weighed. 
Brain slice preparation 
Coronal brain slices (500 μ) containing the SCN were prepared from EtOH-
exposed or EtOH-naïve mice between Zeitgeber Time (ZT) 0 and ZT 4 (where ZT 
0 = lights-on and ZT 12 = lights-off in the animal colony) and maintained in a Hatton-style 
perfusion chamber that received a continuous supply of 95% O2/5% CO2. SCN brain 
slices were perfused continuously with 37°C, oxygenated, glucose/bicarbonate-
supplemented Earle's balanced salt solution (EBSS), pH 7.4. 
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In vitro drug treatments 
Drugs, dissolved in EBSS, were bath applied to the brain slices at ZT 16 or ZT 23 
(i.e., either 4 or 11 hours after lights-off in the previous LD cycle). Drug treatments were 
applied by stopping the perfusion and replacing the medium in the chamber with EBSS 
containing the drug treatment. After 10 minutes, the solution was removed and perfusion 
restarted. Thus, for EtOH-exposed mice, the in vitro drug treatment occurred 
approximately 24 to 30 hours after the bulk of their EtOH consumption and at a minimum 
16 hours after their last exposure to EtOH. Drugs used in the study include glutamate 
(Sigma-Aldrich, St. Louis, MO), EtOH (Decon Laboratories, Inc., King of Prussia, PA), 
and brain-derived neurotrophic factor (BDNF) (Alomone Labs, HarHotzuim, Jerusalem, 
Israel). 
Electrophysiology 
SCN neuronal activity was recorded extracellularly on day 2 in vitro using glass 
microelectrodes. Electrophysiological recordings and analysis were performed with a 
DataWave system (Berthold, CO). Individual cells were recorded for 5 minutes, and 4 to 
6 neurons were recorded each hour. As in previous studies (Prosser 2003; Prosser and 
Glass 2009; Prosser et al 2008), the firing rates of individual neurons were combined to 
generate 2-hour running averages. The time of peak activity was determined by visual 
estimation to the nearest quarter hour (Prosser 2003; Prosser and Glass 2009; Prosser 
et al 2008). Phase shifts were calculated as the difference in time of peak of untreated 
slices from the time of peak of drug-treated slices, because the process of exchanging 
the medium in itself has no effect on the neuronal activity rhythm (Prosser 2003; Prosser 
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and Glass 2009; Prosser et al 2008). The overall experimental design is illustrated in 
Figure 2.1. 
Rapid tolerance duration 
To determine the duration of rapid tolerance, EtOH-exposed mice received 15% 
EtOH for 1 night as usual. The next morning, the EtOH was replaced with water. Mice 
had free access to water for an additional 24, 48, or 72 hours before brain slices were 
prepared (Figure 2.1). Therefore, in these experiments, the in vitro drug treatments were 
applied to the brain slices 48, 72, or 96 hours after the bulk of their EtOH consumption, 
respectively. Brain slice preparation, in vitro drug treatment, and electrophysiological 
recordings were performed as described previously. 
Immunoblots 
SCN brain slices were prepared from either EtOH-naïve or EtOH-exposed mice, 
and drug treatments were performed at ZT 16. Immediately following the drug treatment, 
slices were collected and frozen on dry ice, then stored at −80°C until protein assays were 
performed. Protein was extracted from SCN tissue in ice-cold lysis buffer containing 20% 
radioimmunoprecipitation assay (RIPA) buffer. Protein concentrations were determined 
using a Bradford assay. Whole cell lysate was added in 40 μg quantities into acrylamide 
gels for separation via SDS PAGE. Separated proteins were transferred to polyvinylidene 
difluoride blots and blocked with 5% nonfat dried milk in Tris-buffered saline containing 
20% Tween (TBST) for 1 hour at room temperature. Blots were exposed to NR2B 
(1:1,000; EMD Millipore, Billerica, MA), actin (1:1,000; Santa Cruz Biotechnology, Dallas, 
TX), NR2B p1472 (1:1,000; EMD Millipore), or NR2B p1303 (1:1,000; EMD Millipore) anti-
rabbit polyclonal primary antibodies for 2 hours at room temperature or overnight at 4°C. 
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Blots were washed 3 times with TBST and then exposed to horseradish peroxidase-
conjugated goat anti-rabbit IgG secondary antibodies. After 90 minutes, blots were rinsed, 
luminol solution was applied, and blots were developed using X-ray film exposed to 
chemiluminescent reaction. Blots were analyzed by determining band intensity relative to 
background using ImageJ (NIH, Bethesda, MD). All treatments were normalized to actin. 
Significance was determined using 1-way analysis of variance (ANOVA). 
In vivo assessment of rapid tolerance to EtOH 
Mice housed under 12:12 LD conditions were individually caged and their general 
locomotor activity rhythms were measured over a 2-week pre-experimentation period 
using overhead passive infrared motion detectors interfaced with a data acquisition 
system (Clocklab; Coulbourn Instruments, Whitehall, PA). As in previous studies (Brager 
et al 2010), activity data were collected in 1-minute bins; activity onset associated with 
lights-off (ZT 12) was defined by the initial 6-minute period that (i) coincided with an 
intensity of activity that exceeded 10% of the maximum rate for the day; (ii) was preceded 
by at least 4 hours of activity quiescence; and (iii) was followed by at least 60 minutes of 
sustained activity. Phase shifts were calculated as the difference in projected times of 
activity onset of baseline entrainment and days following EtOH-photic treatment as 
determined by (i) back extrapolation of the least-squares line through activity onsets on 
days 3 to 7 after EtOH-photic treatment and (ii) extrapolation of the least-squares line 
calculated from activity onset data collected the last 5 days of baseline entrainment 
(Brager et al 2010; Ruby et al 2009). Mice had access to EtOH during a single night as 
described earlier. The subsequent night, animals received an intraperitoneal (i.p.) 
injection of EtOH (2.0 g/kg, v/v in physiological saline) or saline alone immediately 
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preceding a 30-minute phase-delaying light pulse (25 lux) delivered from ZT 16 to 16.5. 
Immediately following the light pulse, the animals were released into constant darkness 
(DD) for 2 weeks to assess the extent of phase-delaying using an Aschoff Type II 
procedure (Pittendrigh and Daan 1976). Under DD, activity onset is designated as 
circadian time 12 and is the phase reference point for the onset of the subjective night. 
Statistical analysis 
Differences in the time of peak neuronal activity were assessed using 1-way 
ANOVA. In vivo results were analyzed using a standard t-test. In all cases, the level of 
significance was set at p < 0.05. 
 
Results 
EtOH consumption 
Across all the experiments, mice given access to 15% EtOH drank 2.19 ± 0.06 ml 
of EtOH, which translates to an average consumption of 10.6 g/kg ± 0.32 EtOH (n = 112). 
The SCN circadian clock exhibits rapid tolerance to in vitro EtOH: neuronal activity 
rhythms 
We have shown that in vitro glutamate treatment at ZT 16 delays the phase of the 
SCN neuronal activity rhythm by about 3 hours (Prosser et al 2008). Here, we confirm 
these results, showing that a 10-minute bath application of glutamate (1 mM) at ZT 16 to 
brain slices prepared from an EtOH-naïve mouse induced a 3-hour phase delay 
(Figure 2.2B) relative to the time of peak activity for an untreated slice (Figure 2.2A). 
Again, as previously demonstrated (Prosser et al 2008) in brain slices from EtOH-naïve 
mice, treatment with 1 mM glutamate + 20 mM EtOH inhibited the glutamate-induced 
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phase delay (Figure 2.2C). In slices from EtOH-exposed mice, in vitro glutamate 
treatment continued to induce a 3-hour phase delay (Figure 2.2E); however, 20 mM EtOH 
did not block glutamate-induced phase delays in tissue prepared from EtOH-exposed 
mice. Instead, glutamate continued to induce a 3-hour phase delay (Figure 2.2D). The 
mean phase shifts induced by these treatments are summarized in Figure 2.2E. Because 
this loss of EtOH inhibition was seen approximately 24 hours after EtOH consumption, 
these results are consistent with the induction of rapid tolerance to EtOH. 
Next, we investigated rapid tolerance with respect to glutamate-induced phase 
advances. As shown previously (Prosser et al 2008), bath application of glutamate 
(1 mM) at ZT 23 to SCN slices induced a 3-hour phase advance. Treating brain slices 
from EtOH-naïve mice with 20 mM EtOH in conjunction with glutamate inhibited phase 
advances (mean phase shift = 0.0 ± 0.0 hours, n = 2). However, 20 mM EtOH did not 
inhibit glutamate-induced phase advances in tissue from EtOH-exposed mice 
(Figure 2.3). Thus, our results with treatments at ZT 23 are consistent with those seen 
with ZT 16 treatments. 
The SCN circadian clock exhibits rapid tolerance to EtOH in vivo: behavioral rhythms 
In EtOH-exposed mice, a systemic injection of saline followed by a 30-minute light 
pulse delivered at ZT 16 induced a 0.62 ± 0.17 hour (n = 7) phase delay in the behavioral 
activity rhythms (Figure 2.4A). Previously, we have shown that systemic administration of 
2 g/kg EtOH to EtOH-naïve mice decreases photic-induced phase delays by about 50% 
(Brager et al 2011). However, this same dose of EtOH administered to EtOH-exposed 
mice did not significantly inhibit light-induced phase delays in behavioral activity (mean 
phase delay = 0.86 ± 0.13 hours [n = 7], p = 0.29 vs. saline injection; Figure 2.4B). Thus, 
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the rapid tolerance observed in our SCN brain slices is also seen with photic phase shifts 
of behavioral activity rhythms in intact animals. 
Dose-dependency of EtOH inhibition 
We have shown that in vitro EtOH inhibits glutamate-induced phase delays in 
EtOH-naïve mice with an ED50 of about 10 mM (Prosser et al 2008). Here, we 
investigated whether rapid tolerance to EtOH involves a complete loss of sensitivity to 
EtOH or just a decrease in sensitivity. Thus, we treated SCN brain slices prepared from 
EtOH-exposed mice with 1 mM glutamate at ZT 16 together with varying concentrations 
of EtOH. As seen in Figure 2.5A, the amount of EtOH needed to completely inhibit 
glutamatergic phase delays increased from 20 to 200 mM, with an ED50 between 150 and 
175 mM (Figure 2.5A). A similar shift is seen in the dose–response curve for EtOH 
treatments at ZT 23. Application of 200 mM EtOH completely blocked glutamatergic 
phase advances, with the ED50 again between 150 and 175 mM (Figure 2.5B). 
BDNF reverses EtOH inhibition of glutamatergic phase shifts 
We have shown that co-treatment of BDNF with glutamate and EtOH prevents 
acute EtOH inhibition of glutamate-induced phase shifts in tissue prepared from EtOH-
naïve mice (Prosser et al 2008). Here, we investigated if this occurs in tissue prepared 
from EtOH-exposed mice. First, we repeated our previous experiments with brain slices 
from EtOH-naïve mice at ZT 16, showing that co-application of 100 ng/ml BDNF with 
1 mM glutamate and 20 mM EtOH resulted in phase delays of 2.3 ± 0.45 hours, n = 3 
(Figure 2.2E), indicating that BDNF blocked EtOH inhibition. Next, we tested brain slices 
from EtOH-exposed mice, applying 100 ng/ml BDNF together with 200 mM EtOH and 
1 mM glutamate. BDNF rescued glutamate-induced phase delays in brain slices from 
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EtOH-exposed mice as well (Figure 2.2E). Control experiments indicated that applying 
EtOH and BDNF together in the absence of glutamate did not induce phase shifts 
(Figure 2.2E). [Previous work indicates that BDNF and EtOH applied separately do not 
induce phase shifts (Mou et al 2009; Prosser et al 2008)]. We also investigated these 
treatments at ZT 23. Similar to our results at ZT 16, adding 100ng/mL BDNF rescued 
glutamate-induced phase advances blocked by 200 mM EtOH, resulting in a 
2.7 ± 0.15 hour phase advance (n = 3) (Figure 2.3). Again, control experiments confirmed 
that EtOH and BDNF did not induce phase shifts when applied concurrently (Figure 2.3). 
Thus, BDNF reverses EtOH inhibition of in vitro glutamate-induced phase shifts in brain 
slices from both EtOH-naïve and EtOH-exposed mice. 
Duration of rapid tolerance 
To determine how long rapid tolerance to EtOH persists in the SCN, we modified 
the experimental protocol by expanding the time between in vivo EtOH consumption and 
brain slice preparation. Thus, brain slices were prepared 24, 48, or 72 hours after access 
to EtOH ended. These brain slices were then treated with EtOH + glutamate the 
subsequent subjective night at either ZT 16 or ZT 23, as in previous experiments. Thus, 
for brain slices prepared 24 hours after EtOH access ended, ZT 16 treatments were 
applied approximately 48 hours after the majority of EtOH consumption, while for slices 
prepared 48 hours after EtOH access ended, ZT 16 treatments were applied 
approximately 72 hours after the majority of EtOH consumption. Given this time frame, 
co-treatment with glutamate and EtOH 48 hours after the majority of EtOH consumption 
resulted in phase delays of 3.2 ± 0.14 hours, n = 3, indicating continued tolerance, while 
co-treatment with glutamate and EtOH 72 hours after the bulk of EtOH consumption 
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resulted in no significant phase delay (0.45 ± 0.07 hours, n = 3; Figure 2.6A). Thus, rapid 
tolerance to EtOH inhibition of glutamate-induced phase delays is lost between 48 and 
72 hours after the majority of EtOH consumption. With respect to ZT 23 experiments, the 
tolerance to EtOH appears to last longer. Phase advances were seen after co-
administration of EtOH and glutamate 48 and 72 hours after EtOH consumption, (mean 
phase shifts = 2.875 ± 2.04 hours, n = 2 and 3.1 ± 0.29 hours, n = 3, respectively) but not 
when they were co-applied approximately 96 hours after EtOH consumption ended (mean 
phase shift = 0.0 ± 0.20 hours, n = 3) (Figure 2.6B). Thus, for glutamate-induced phase 
advances, rapid tolerance to EtOH appears to last between 72 and 96 hours after EtOH 
consumption. 
Effects of EtOH on NR2B expression and phosphorylation 
Our data suggest that SCN tissue develops tolerance to EtOH at both ZT 16 and 
ZT 23. To begin investigating potential cellular mechanisms underlying this effect, we 
focused on N-methyl-D-aspartate (NMDA) receptors in the SCN. Using immunoblot 
analysis, we first focused on EtOH-naïve SCN tissue. Tissue samples were probed for 
total NR2B and Y1472-phosphorylated NR2B receptor levels. Blot analysis showed that 
in EtOH-naïve tissue neither total NR2B expression nor Y1472-phosphorylated NR2B 
expression were significantly altered by any of the treatments when compared to control 
(n = 5, p > 0.966) (Figure 2.7A). Next, we probed for the expression of total NR2B along 
with NR2B phosphorylated at either Y1472 or S1303 in EtOH-exposed tissue. Y1472 and 
S1303 are phosphorylated by Src family proteins and CAM kinase II, respectively. 
Analysis again revealed no significant differences across treatments (n = 3, p > 0.711) 
(Figure 2.7B). Thus, we found no differences in the level of total NR2B expression in the 
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SCN or in the level of NR2B phosphorylation at Y1472 and S1303 in EtOH-naïve and 
EtOH-exposed tissue. 
 
Discussion 
The SCN clock exhibits rapid tolerance to EtOH 
Chronic alcohol abuse is characterized by a self-perpetuating spiral of decreasing 
alcohol sensitivity and increasing consumption (Kalant 1998). A better understanding of 
the cellular processes underlying alcohol desensitization may help to develop treatments 
that alleviate or prevent this debilitating cycle of dependence. The propensity to develop 
rapid tolerance has been linked to the development of chronic tolerance (Khanna 
et al 1991). Here, we show for the first time that the SCN circadian clock exhibits rapid 
tolerance to EtOH. Importantly, this tolerance is seen in vivo as well as in vitro. Rapid 
tolerance in the SCN in vitro is manifest as a 10-fold shift in the dose–response curve for 
EtOH inhibition of glutamate-induced phase-advance and phase-delay shifts; it is 
apparent 24 hours after initial exposure to EtOH; and it lasts for several days. Future 
experiments could determine whether rapid tolerance in vivo exhibits similar 
characteristics by increasing the concentration of EtOH administered i.p. and by 
increasing the time interval between EtOH consumption and testing for EtOH inhibition of 
photic phase shifts. 
Time course of rapid tolerance 
We have previously shown that EtOH inhibits in vitro glutamate-induced phase 
delays and phase advances and that the SCN clock develops an acute form of tolerance 
to EtOH within 5 to 15 minutes (Prosser and Glass 2009). This acute tolerance does not 
64  
dissipate with maintained EtOH application for at least 3 hours. That study did not 
determine the duration of acute tolerance after EtOH removal, but a previous report 
indicates that acute tolerance is lost 24 hours after EtOH exposure (Allen and Harris, 
1987). This time course, in part, helps to differentiate acute tolerance from rapid 
tolerance. 
Rapid tolerance develops more slowly than acute tolerance, being initially seen 8 
to 24 hours after exposure (Crabbe et al 1979; Kalant 1998). In this study, our 
experimental design precludes an accurate estimation of the time course of tolerance 
development, because we utilized self-administration of EtOH by the mice over the course 
of a 12-hour lights-off period, and we did not monitor the timing of EtOH consumption. 
The minimum time between EtOH consumption and when EtOH was applied to the brain 
slices (or administered to the mice in vivo) was 16 hours. However, based on typical 
nocturnal drinking patterns in mice (Brager et al 2010), the actual time between the 2 
EtOH exposures was likely closer to 24 hours. To more narrowly define the time course 
of tolerance development, the time of EtOH access by the mice would have to be further 
restricted. 
An issue not previously addressed in the literature is the persistence of rapid 
tolerance. We investigated this issue with both early night phase delays and late night 
phase advances. For glutamate/EtOH treatments at ZT 16, we found that tolerance lasts 
at least 48 hours after EtOH exposure but is no longer present after 72 hours. As the 
experiment requires tolerance assessment at times when glutamate phase shifts the 
circadian clock, we are limited in our ability to define the time course more precisely. 
Interestingly, rapid tolerance appears to last between 72 and 96 hours for ZT 23 co-
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treatments with glutamate and EtOH. This difference in time course may be related to the 
distinct cellular mechanisms associated with circadian clock phase delays and phase 
advances (Gillette and Mitchell 2002). Determining differences in the cellular responses 
to alcohol through phase delay/advance mechanisms could provide key information on 
how alcohol affects neuronal cellular dynamics, especially those associated with the 
development of tolerance. 
BDNF reverses EtOH inhibition of glutamatergic phase shifts in EtOH-exposed mice 
In these experiments, rapid tolerance in the SCN was characterized by a lack of 
response to the lower (20 mM) concentration of EtOH, while a 10-fold higher 
concentration was able to inhibit glutamate-induced phase shifts. This higher EtOH 
concentration could potentially affect different cellular mechanisms than the lower 
concentrations: many studies have demonstrated dose-dependent differences in receptor 
sensitivity to EtOH, including GABA (Wakita et al 2012; Wu et al 2005) and glutamate 
(Allgaier 2002; Blevins et al 1997; Proctor et al 2006) receptors. Our previous 
experiments demonstrated that BDNF prevents acute EtOH inhibition of glutamate-
induced phase shifts (Prosser et al 2008), suggesting that EtOH acts in part by inhibiting 
BDNF actions. Therefore, as an initial assessment of potential differences in cellular 
mechanisms, in these experiments, we investigated whether the inhibition induced by 
200 mM EtOH likewise was sensitive to reversal by BDNF. Our results show that BDNF 
still reverses EtOH inhibition during rapid tolerance, suggesting that similar cell signaling 
processes underlie EtOH's actions under both conditions. 
As application of BDNF can enhance NMDA receptor activity, it is possible that 
rapid tolerance in the SCN involves changes in either NMDA (glutamate) or TrkB (BDNF) 
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receptors. Previous studies determined that NMDA receptor antagonists can prevent 
rapid tolerance (Khanna et al., 1991). Others indicate that NMDA receptors, especially its 
NR2B subunit, play a major role in the onset of tolerance (Yaka et al., 2003). Both acute 
and chronic EtOH exposure can alter NMDA receptor biochemistry by decreasing 
phosphorylation at the Y1472 residue (Wu et al 2010), but whether similar changes occur 
with rapid tolerance is not known. We hypothesized that rapid tolerance could involve 
either increased NR2B expression and/or enhanced phosphorylation at NR2B Y1472 
residue. However, our data do not support this hypothesis. There are several possible 
explanations: First, it is possible that the changes underlying rapid tolerance do not 
include changes in NR2B expression and phosphorylation. If true, this would differentiate 
rapid tolerance from both acute and chronic tolerance (Läck et al 2005; Miyakawa 
et al 1997; Nagy 2008; Roberto et al 2006; Trepanier et al 2012). Second, rapid tolerance 
may involve compensatory responses upstream and/or downstream of NMDA receptors. 
For example, chronic EtOH induces increases in striatal enriched tyrosine phosphatase-
33 (STEP-33) and p38 mitogen activated protein kinase (MAPK), without altering Src, 
Lyn, and Fyn kinases (Wu et al 2010). It may be worthwhile investigating these molecules 
in future experiments with rapid tolerance. Third, changes in NMDA receptor membrane 
localization could play a role in rapid tolerance. Future experiments using biotinylation 
could begin to address this possibility. Last, rapid tolerance may involve other receptors, 
such as TrkB or GABA(A) receptors that are known to play critical roles in the SCN. For 
example, BDNF enhances NMDA currents in the SCN (Kim et al 2006), so rapid tolerance 
could involve an increase in TrkB signaling. Also, a previous study found that EtOH acts 
in the SCN at least partially through activating GABA receptors (McElroy et al 2009). 
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Therefore, it will be important to determine whether rapid tolerance is associated with 
decreases in GABA signaling in the SCN. Importantly, due to the different durations of 
rapid tolerance, we observed regarding glutamate-induced phase delays and phase 
advances, it will be important to assess these cellular mechanisms with respect to phase 
advances in addition to phase delays. 
 
Summary: the different manifestations of EtOH tolerance 
Broadly speaking, to better understand the mechanisms leading to alcohol abuse, 
it is important to clarify the different forms of tolerance at the behavioral, physiological, 
and molecular levels. Acute EtOH exposure is associated with transient changes in 
receptor signaling, whereas chronic EtOH exposure leads to changes in receptor 
expression and localization, and intracellular signaling processes. Rapid tolerance lies 
somewhere in between, and its relationship with the other 2 forms of tolerance is uncertain 
(Lovinger and Roberto 2013). Although we have shown that acute tolerance develops in 
vitro (Prosser and Glass 2009) determining whether it occurs in vivo is technically difficult. 
Rapid tolerance, we show here, occurs both in vitro and in vivo with respect to EtOH 
modulation of the SCN circadian clock. Interestingly, our previous research indicates that 
chronic tolerance may not develop in vivo (Brager et al 2010). However, results from 
another study suggest the lack of chronic tolerance seen in our experiments may be due 
to using no-choice EtOH versus free-choice EtOH drinking (Seggio et al 2009). In light of 
reports suggesting that developing rapid tolerance correlates with the propensity to 
develop chronic tolerance (Khanna et al 1991; Radcliffe et al 2006; Wu et al 2001), the 
possible lack of chronic tolerance in vivo is surprising. There could be compensatory 
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changes outside the SCN that counteract a decrease in circadian clock sensitivity to 
chronic EtOH, or the SCN circadian clock could somehow be immune to chronic EtOH 
tolerance. We should be able to distinguish between these possibilities in our in vitro 
preparation by investigating whether chronic tolerance is seen in SCN brain slices. It will 
also be interesting to investigate potential differences in cellular changes depending on 
the mode of EtOH administration. 
 
Significance 
Rapid tolerance to EtOH has been linked to the development of chronic tolerance, 
a critical step toward alcohol dependency and abuse (Khanna et al 1991; Radcliffe 
et al 2006; Wu et al 2001). Therefore, determining the physiological and molecular 
characteristics that differentiate the forms of EtOH tolerance should help elucidate the 
processes that lead to alcohol abuse, and possibly identify treatments that could prevent 
that progression. Our demonstration that rapid tolerance is seen with the SCN circadian 
system at the cellular and behavioral levels through the use of complementary in vivo and 
in vitro experimental paradigms further proves its usefulness for investigating the direct 
connections between cellular actions of EtOH and its behavioral manifestations. 
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Figure 2.1 In vitro rapid tolerance experimental protocol. On Day 1, mice are allowed 
overnight access to 15% ethanol (EtOH). At lights-on of Day 2, mice are sacrificed and 
suprachiasmatic nucleus (SCN) brain slices are prepared. At Zeitgeber Time (ZT) 16 or 
ZT 23, brain slices receive drug treatment. After 10 minutes, drug treatment is removed, 
and slices are left undisturbed until the next day. On Day 3, electrophysiological 
recordings of SCN neuronal activity are conducted. For tolerance duration experiments, 
an additional 1 to 3 days of water-only access were added to the protocol between the 
single night of EtOH access and when brain slices were prepared. 
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Figure 2.2 Rapid tolerance to ethanol (EtOH) inhibition of glutamate-induced phase 
delays. Shown are the 2-hour mean ± SEM of suprachiasmatic nucleus neuronal activity 
obtained in individual experiments. (A) Control experiment with no drug treatment 
showing normal time of peak activity at Zeitgeber Time 6 (ZT 6). (B) A 10-min bath 
application of glutamate (1 mM) at ZT 16 to brain slices prepared from an EtOH-naïve 
mouse induces a 3-hour phase delay. (C) Treating brain slices from an EtOH-naïve 
mouse with 1 mM glutamate + 20 mM EtOH leads to no shift, indicating that the 
glutamate-induced phase delay is inhibited. (D) The 20 mM EtOH does not block 
glutamate-induced phase delays in brain slices prepared from an EtOH-exposed mouse. 
Horizontal bars: time of lights-off in the animal colony; vertical bars: time of drug 
treatment(s); dotted line: mean time of peak in control experiments. (E) Shown are the 
mean (±SEM) phase shifts induced in experiments involving various combinations of 
glutamate, EtOH, and brain-derived neurotrophic factor (BDNF) bath applied at ZT 16. 
EtOH inhibits glutamate-induced phase delays in brain slices from EtOH naïve mice, and 
this effect is reversed by co-application of 100 ng/ml BDNF. In brain slices from EtOH-
exposed mice 20 mM EtOH does not block glutamate-induced phase delays, while 
200 mM EtOH completely blocks glutamate-induced phase delays. Again, this inhibition 
by EtOH is reversed by co-application of 100 ng/ml BDNF. Co-treatment with BDNF and 
EtOH alone had no effect on brain slices from either EtOH naïve or EtOH-exposed mice. 
One-way ANOVA indicated a significant effect of treatment, F(29) = 14.4. *Post hoc 
(Holm-Sidak) test indicates p < 0.001 versus control experiments. 
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Figure 2.3 Rapid tolerance to ethanol (EtOH) inhibition of glutamate-induced phase 
advances. Shown is a summary of mean (± SEM) phase-shifts induced in experiments 
involving various combinations of glutamate, EtOH and brain-derived neurotrophic factor 
(BDNF) bath applied at Zeitgeber Time 23 (ZT 23) in tissue from mice exposed to EtOH 
24 hours prior to treatment. EtOH 20 mM does not inhibit glutamate-induced phase 
advances. However, raising the concentration to 200 mM EtOH inhibits glutamate-
induced phase advances. This effect is reversed by co-application of 100 ng/ml BDNF. 
*p < 0.001 vs. controls, post hoc (Holm-Sidak) test. 
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Figure 2.4 Rapid tolerance to inhibition of photic phase shifts in vivo. (A) Representative 
double-plotted actograms of general locomotor activity showing the effects of systemic 
injection of saline (top) and 2 g/kg ethanol (EtOH) (bottom). Injection was performed 
immediately prior to a 30 minute light pulse at ZT 16. Black arrows represent time of drug 
administration and light pulse. (B) Shown is the mean phase shift induced by a 30-minute 
light pulse at ZT 16 with systemic injection of either saline or 2 g/kg EtOH prior to light 
pulse in mice given access to EtOH the previous night. Bars are the mean ± SE. Phase 
delays for saline (0.62 ± 0.17 hours, n = 7) and EtOH (0.86 ± 0.13 hours, n = 7) are not 
significantly different (p = 0.29). 
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Figure 2.5 (A) Dose–response curves for ethanol (EtOH) inhibition of glutamate-induced 
phase delays in vitro in brain slices prepared from EtOH–naïve (black dots) and EtOH-
exposed (white triangles) mice. (Data from EtOH-naïve mice replotted from Prosser et al. 
[[1]] for the ease of comparison.) (B) Dose–response curves for EtOH inhibition of 
glutamate-induced phase advances in vitro in brain slices prepared from EtOH-exposed 
mice. In both cases, the glutamate-induced phase shifts in brain slices from EtOH-
exposed mice are completely inhibited by 200 mM EtOH, with an ED50between 150 and 
175 mM. 
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Figure 2.6 Rapid tolerance duration for ethanol (EtOH) inhibition of glutamate-induced 
with phase delays and phase advances. (A) Shown are the mean (±SEM) phase shifts 
induced by co-application of 1 mM glutamate and 20 mM EtOH to brain slices prepared 
from mice that consumed 15% EtOH either 24, 48, or 72 hours prior to drug treatment at 
Zeitgeber Time 16 (ZT 16). Glutamate-induced phase delays are insensitive to EtOH 
inhibition at 24 and 48 hours after EtOH consumption but are completely blocked by EtOH 
72 hours after EtOH consumption. (B) Shown are the mean (±SEM) phase shifts induced 
by co-application of 1 mM glutamate and 20 mM EtOH to brain slices prepared from mice 
that consumed 15% EtOH either 24, 48, 72, or 96 hours prior to drug treatment at ZT 23. 
Glutamate-induced phase advances are insensitive to EtOH inhibition at 24, 48, and 
72 hours after EtOH consumption but are completely blocked by EtOH 96 hours after 
EtOH consumption. 
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Figure 2.7 The effects of glutamate, ethanol (EtOH), and brain-derived neurotrophic 
factor (BDNF) application on N-methyl-D-aspartate receptor subunit NR2B and NR2B 
phosphorylation levels in EtOH-naïve and EtOH-exposed slices. (A) NR2B subunit 
expression and Y1472 residue phosphorylation levels in suprachiasmatic nucleus (SCN) 
brain slices prepared from EtOH-naïve mice. The treatments are as follows: no-treatment 
control (Ctl); 1 mM glutamate (Glu); 1 mM glutamate and 20 mM EtOH (Glu+EtOH); 1 mM 
glutamate, 20 mM EtOH, and 100 ng/mL BDNF (Glu+EtOH+BDNF); 20 mM EtOH and 
100 ng/mL BDNF (EtOH+BDNF). Each group represents 4 independent replicates. (B) 
NR2B subunit expression, Y1472 residue phosphorylation, and S1303 residue 
phosphorylation in SCN brain slices prepared from EtOH-exposed mice. The treatments 
for EtOH-exposed slices are as follows: rapid tolerance with no treatment (RTC); EtOH-
naïve with no treatment (NoEC); 1 mM glutamate (Glu); 1 mM glutamate and 20 mM 
EtOH (Glu+EtOH20); 1 mM glutamate and 200 mM EtOH (Glu+EtOH200); 1 mM 
glutamate, 200 mM EtOH, and 100 ng/mL BDNF (Glu+EtOH200+BDNF); 1 mM 
glutamate and 100 ng/mL BDNF (Glu+BDNF). Each group represents 2 to 3 independent 
replicates. 
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Chapter 3 
Changes in NMDA Receptor and NMDA Receptor Signaling-Associated 
Characteristics During Ethanol Tolerance and Withdrawal in the Suprachiasmatic 
Nucleus. 
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Abstract 
Alcohol tolerance and withdrawal induced effects are criteria for alcohol use 
disorders listed by the DSM-V. Although tolerance and withdrawal have been studied 
extensively over many decades, there is still uncertainty regarding the mechanistic 
distinctions that characterize the different forms of tolerance. Gaps in the existing 
literature include a lack of research on the cellular mechanisms underlying each form of 
EtOH-induced change, inconsistencies in the experimental procedures investigating a 
specific region across multiple studies, and not having demonstrated multiple tolerance 
forms in a single brain region. The suprachiasmatic nucleus (SCN) is the primary clock 
oscillator that regulates the timing of mammalian biological rhythms. Previous work has 
demonstrated that ethanol (EtOH) blocks photic phase shifts. Interestingly, both acute 
and rapid tolerance have been shown to develop in the SCN, with respect to EtOH 
inhibition of glutamate-induced phase shifts. Here, we demonstrate using our in vitro 
analysis that chronic tolerance and withdrawal induced hypersensitization to glutamate 
also occur. For our drinking model investigating chronic tolerance, we allowed mice to 
consume EtOH for 4 h each day, with access to 15% EtOH starting one hour prior to lights 
out through three hours after lights out. Tolerance developed after 10 days of 4 h EtOH 
access, as indicated by a decreased sensitivity to EtOH inhibition of glutamate-induced 
phase shifts. For withdrawal, we used the 4 hour access model for 21 days followed by 
two days of withdrawal. We observed an increased sensitivity to glutamate–induced 
phase shifts in SCN tissue following withdrawal, consistent with withdrawal induced 
hyperexcitability. Additionally, we used Western blotting to compare changes in NMDA 
receptors and associated proteins across multiple forms of EtOH plasticity, including rapid 
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tolerance, chronic tolerance, and EtOH withdrawal. We demonstrated an increase in 
NR2B/NR2A total expression ratios after 21 days of drinking and after EtOH withdrawal, 
and an increase in phosphorylation of Y1472 during withdrawal. Furthermore, we also 
detected an increase in mature BDNF and p-TrkB during withdrawal. These results 
demonstrate that multiple tolerance forms and withdrawal induced hypersensitization 
occur in the SCN; that chronic drinking and EtOH withdrawal change the subunit 
composition of NMDA receptors in the SCN; and that increases in mBDNF, TrkB 
phosphorylation, and Y1472 phosphorylation occur during EtOH withdrawal. Importantly, 
this study further demonstrates the power of using the SCN as a model system to 
investigate EtOH induced plasticity.  
 
Introduction 
Alcohol use disorder (AUD) is a condition that develops after long periods of 
ethanol (EtOH) consumption. Many studies have investigated the cellular processes 
associated with AUD. However, a major complication in AUD research is that the effects 
of EtOH change as one progresses from short-term to long-term drinking. The acute 
effects of EtOH include inhibition of glutamate signaling and enhancement of GABA 
signaling (Roberto et al 2004; Proctor et al 2006; Moykkynen and Korpi 2012; Hughes et 
al 2013). As EtOH exposure increases, changes in synaptic localization, total expression, 
and phosphorylation of receptor proteins occur (Hendricson et al 2004; Roberto et al 
2004; Clapp et al 2010; Wu et al 2010). These effects are seen throughout the brain, 
although the specific changes appear to differ regionally. Complicating the picture is that 
varying EtOH exposure paradigms have been used to investigate changes in different 
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brain areas, including in the suprachiasmatic nucleus (SCN) (Prosser et al 2008; Brager 
et al 2010; Ruby et al 2009; Seggio et al 2009; Prosser and Glass 2009; Lindsay et al 
2014; Rosenwasser et al 2014). 
A critical component of the transition from social drinking to EtOH abuse is thought 
to be the development of tolerance, where increasing amounts of alcohol are consumed 
to achieve the same effects. Three major forms of EtOH tolerance have been described 
that differ based on time after initial exposure – acute tolerance (develops 5-15 minutes 
after drinking), rapid tolerance (develops 8-24 hours after drinking), and chronic tolerance 
(occurs after days/weeks of ethanol exposure). For example, acute tolerance has been 
measured with respect to ataxia and motor impairment (Gill and Deitrich, 1998; Ramirez 
et al 2011), rapid tolerance with hypothermic and hypnotic effects (Gilliam 1989; Silveri 
and Spear 1999), and chronic tolerance with circadian activity rhythms and loss of righting 
reflex (Rosenwasser et al 2014; Daut et al 2015). Although the mechanisms underlying 
these different forms of tolerance are still under investigation, many cellular changes have 
been noted. With tolerance in general, glutamatergic and γ-aminobutyric acid (GABA) 
signaling mechanisms adapt to increase and decrease baseline signaling properties, 
respectively. Acute tolerance has been linked to increased expression of N-methyl-D-
aspartate (NMDA) receptor NR2A and NR2B subunits in the hippocampus and cortex 
(Roh et al 2011). Transgenic studies also suggest a role for α1 subunits of GABA 
receptors in acute tolerance (Werner et al 2006; Werner et al 2009). In two separate 
studies, applying α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor 
(AMPA) receptor and NMDA receptor antagonists block rapid tolerance associated with 
motor coordination and hypothermic effects of ethanol (Rial et al 2009; Khanna et al 
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1997). Finally, changes in total expression and phosphorylation of key residues of NMDA 
receptor and GABA receptor subunits have been demonstrated during chronic EtOH 
tolerance (Wu et al 2010; Kroener et al, 2012; Honse et al 2003; Suvarna et al 2005; 
Wang et al 2011; Ravindran et al 2007, Liang et al 2007, Gonzalez et al 2012, Lindemeyer 
et al 2014). Ethanol withdrawal following chronic exposure is typically characterized by 
insomnia, psychomotor agitation, hallucination, and delirium tremens (Schuckit 2014). At 
the cellular level, withdrawal induces dramatic changes in glutamate and GABA signaling 
(Clapp et al 2010; Reynolds et al 2015; Kumar et al 2009; Carlson et al 2016).  
In summary, the cellular mechanisms associated with acute, rapid, and chronic 
EtOH tolerance, and EtOH withdrawal appear to differ (Grobin et al 1998; Radcliffe et al 
2006; Roberto et al 2006; Ward et al 2009; Clapp et al 2010: Lindsay et al 2014; Tran et 
al 2015). However, rarely have the cellular mechanisms underlying each of these forms 
of EtOH-induced plasticity been assessed in a single study or in a single brain region. 
Thus our goal was to assess changes in the SCN across multiple forms of EtOH tolerance 
and EtOH withdrawal.  
We use the SCN circadian clock as a model system to investigate EtOH. The 
circadian clock in the SCN is the primary endogenous oscillator that regulates daily 
rhythms in behavior and physiology in mammals. External cues such as light phase-shift 
the circadian clock in order to maintain proper synchrony with the environment. Light-
induced phase resetting in the SCN clock requires NMDA receptor activation (Ding et al 
1997; Mintz et al 1999; Wang et al 2008). Numerous studies have shown that EtOH 
disrupts the ability of the SCN clock to respond to synchronizing cues such as light. For 
example, EtOH administration alters circadian clock period in vivo, and inhibits photic 
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phase resetting in rodents acutely in vivo (Prosser and Glass 2009; Ruby et al 2009), 
acutely in vitro (Prosser et al 2008; Prosser and Glass 2009), and chronically in vivo 
(Rosenwasser et al 2005; Seggio et al 2007; Ruby et al 2009; Seggio et al 2009; Brager 
et al 2010). Because EtOH is known to disrupt NMDA receptor function across a variety 
of exposure paradigms, we chose NMDA receptors as our primary focus for these 
experiments. Previously we showed that acute and rapid tolerance to EtOH occur in the 
SCN in mice (Prosser and Glass 2009; Lindsay et al 2014). Here we expand upon these 
studies, showing that chronic tolerance and withdrawal-induced glutamate 
hypersensitivity also develop in the SCN in vitro, and these EtOH-induced changes are 
each accompanied by distinct changes in specific parameters of NMDA receptor 
expression.  
 
Materials and methods 
Mice 
Adult (~8 week old) C57BL/6 adult male mice were obtained from Harlan 
Laboratories (Frederick, MD). Mice were individually housed in polycarbonate cages 
under a 12:12 light/dark (LD) cycle, with food and water available ad libitum unless 
otherwise noted. The experiments followed the National Institution of Health Guidelines 
for the Care and Use of Laboratory Animals and were approved by the University of 
Tennessee Knoxville Institutional Animal Care and Use Committee. In all experiments, 
mice were allowed access to either water or 15% EtOH from drip-resistant sipping tubes 
(Medical Associates, Inc., St. Albans, VT).  
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Brain slice preparation, and drinking schedules 
A rapid tolerance drinking schedule was performed as described in Lindsay et al 
2014. Briefly, mice had their water bottle replaced with one containing a 15% EtOH/water 
solution for a single 12 h lights-off period. At lights-on following EtOH access, the volume 
of EtOH consumed and the weight of the mouse was recorded. Afterwards, 500 um 
coronal brain slices containing the SCN were prepared for electrophysiological recording 
or for Western blot assays. Brain slices were maintained at 37°C in an interface style 
brain slice chamber and perfused with Earle’s balanced salt solution (EBSS), pH 7.4, 
supplemented with 95% O2/5% CO2, sodium bicarbonate, glucose and gentamicin.  
To investigate chronic tolerance, a 4h/day drinking protocol was used. This 
involved exchanging the water bottles with ones containing a 15% EtOH/water solution 
beginning one hour prior to lights off and continuing through 3 hours after lights off, for a 
total of 4 hours. EtOH and water consumption and body weight of each mouse was 
measured daily. The 4h EtOH access protocol continued for 10-21 days depending on 
the exact experiment. At lights-on after the last day of drinking, coronal brain slices 
containing the SCN were prepared and maintained as described above.  
For EtOH withdrawal, mice underwent the chronic drinking protocol for up to 21 
days followed by 2-6 days with no EtOH access (food and water were available ad-
libitum). At lights-on following the withdrawal period, coronal brain slices were prepared 
and maintained as described above. 
Drug treatment 
During the first night after brain slice preparation, SCN tissue received bath 
application of drugs dissolved in EBSS at Zeitgeber time (ZT) 16 (where ZT 0 = lights-on 
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and ZT 12 = lights-off in the animal colony). Drug treatments were performed by stopping 
the perfusion and replacing perfusion media with EBSS containing the drug treatment for 
10 minutes. Afterwards, the solution was removed and the perfusion was resumed. Drug 
treatments contained a combination of glutamate (Sigma Aldrich, St. Louis, MO) and 
EtOH (Decon Laboratories, Inc., King of Prussia, PA). SCN tissue used for Western blot 
and biotinylation assays did not receive drug treatments but rather were collected at 
Zeitgeber time (ZT) 6, 16, or 23 and stored at -80°C until protein extraction. 
Electrophysiological recordings 
Extracellular single-unit recordings commenced the morning of the second day in 
vitro. Recordings were performed using glass microelectrodes filled with 5M NaCl as in 
previous studies (Prosser 2003; Prosser et al 2008; Prosser and Glass 2009).  Each cell 
was recorded for 5 minutes, with at least 5 cells recorded per hour over the course of a 
ten-hour period. Recordings and firing rate analysis were done using DataWave software 
(Loveland, CO). The firing rates of individual neurons were combined into 2 h running 
averages, and the peak in neuronal activity was assessed visually as the time of 
symmetrically highest activity calculated to the nearest quarter hour (Prosser 2003; 
Prosser et al 2008; Prosser and Glass 2009).  
Protein extraction 
SCN tissue samples were thawed, placed in RIPA lysis buffer containing 1mM Tris 
pH 8.8, 5mM SDC, 5mM SDS, 1% triton, protease inhibitor cocktail (Thermo Scientific, 
Waltham, MA), and phosphatase inhibitor cocktail (Thermo Scientific), and lysed using 
15 sec sonication pulses. The supernatant was separated from the pellet using 
centrifugation at 13000 rpm at 4°C. Protein concentrations were determined using a 
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Bradford assay. The supernatant was then loaded into a 7% poly-acrylamide gel and 
electrophoresis was performed. Proteins were transferred to a polyvinylidene fluoride 
(PVDF) FL immobilon membrane (EMD Millipore, Billerica, MA) using the Transblot turbo 
system (Bio-Rad Laboratories, Hercules, CA). 
Western blot assays 
Following protein extraction, Western blots were performed as reported previously 
(Lindsay et al 2014). Briefly, PVDF membranes were blocked with 5% milk in TBST then 
incubated with primary antibodies for 2 hours at room temperature or overnight at 4°C. 
Primary antibodies used were: α-phospho-Y1472 (1:1000, EMD Millipore), α-phospho-
S1480 (1:1000, AbCam, Cambridge, United Kindgdom), α-NR2B (1:1000, EMD 
Millipore), α-NR1 (1:1000, AbCam), α-NR2A (1:1000, EMD Millipore), α-PSD-95 (1:2000, 
EMD Millipore), α-BDNF (detects both mature and pro BDNF; 1:200, Santa Cruz 
Biotechnology, Dallas, TX), α-TrkB (detects both full length and truncated TrkB; 1:200, 
Santa Cruz), α-phospho-tropomyosin receptor kinase A Y680 (binds correspondingly to 
Y706 of TrkB; 1:200, Santa Cruz), and α-Actin HRP conjugate (Santa Cruz 
Biotechnology, Dallas, TX). After rinsing, blots were exposed to secondary antibodies of 
goat α-Rabbit (Vector Laboratories, Burlingame, CA), goat α-Mouse (Vector 
Laboratories), donkey α-Rabbit (Li-COR, Lincoln, NE), or donkey α-Goat (Li-COR) 
conjugated to horseradish peroxidase or infrared dye (LI-COR). Blots were allowed to 
incubate for an hour and a half with secondary antibodies. Protein bands were detected 
on Green x-ray film (Thermo Scientific) in experiments using chemilumenescence or 
using the Imagestudio program in experiments using fluorescent dye.  
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Cell surface biotinylation 
SCN brain slices removed from the perfusion chamber at ZT 6, 16, or 23 were 
placed in EBSS containing 1mg/mL NHS-SS-biotin (Thermo Scientific) for 75 min on ice. 
The reaction was halted by addition of 1mM glycine. Slices were then rinsed with ice cold 
EBSS and stored at -80°C until protein extraction. The extracted protein samples were 
run through desalting columns in a centrifuge for 2 min at 4°C. Neutravidin ultralink resin 
(200mL; Thermo Scientific) was added to samples and incubated overnight at 4°C. The 
next day the avidin resin was separated from the flow-through via centrifugation and 
collecting the supernatant (flow-through). Flow-through was kept for control purposes. 
The avidin resin was then rinsed three times with lysis buffer. Sample and flow-through 
were boiled for 5 minutes at 100°C. Samples and flow-through were loaded into poly-
acrylamide gels. Protein samples were then transferred to PVDF after separation of 
proteins on the gel, and Western blot assays were performed as described above.   
Statistical methods 
All statistical analysis was performed using SigmaPlot. Individual mice were experimental 
units for electrophysiological recordings. Tissue from a single mouse (or pooled samples 
when necessary) were the experimental unit for Western blots and biotinylation 
experiments. Post-hoc Holm-Sidak analysis using t-test or ANOVA was used between 
two comparisons or among multiple comparisons for each experiment, respectively. 
Significance was considered when P < 0.05.  
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Results 
EtOH consumption across multiple treatments 
Mice allowed to consume EtOH for a single 12 h lights-off period had an average 
EtOH consumption of 10.62 ± 0.32 g/kg, n=112. Mice given 4 h of daily access to EtOH 
for 10 days had an average daily EtOH consumption of 3.36 ± 0.23 g/kg/day, n=93. Mice 
given 4 h of daily access to EtOH for 21 days had an average daily EtOH consumption of 
2.52 ± 0.24 g/kg/day, n=29. Because all experiments assessed SCN tissue that had been 
maintained in vitro for a minimum of 4 h, we did not measure blood alcohol levels in the 
mice. 
Chronic tolerance to EtOH occurs in the SCN 
In brain slices prepared from EtOH naïve mice, firing rates normally peak at ZT6 
(Figure 3.1A). The mean time of peak in control slices occurred at 6.1±0.30 n=3, which is 
consistent with previous research (e.g., Prosser et al 2008). Glutamate applied at ZT16 
to SCN slices from EtOH naïve mice induces a phase delay of ~3 hours (Figure 3.1B), 
which is inhibited by co-application of 20 mM EtOH (Figure 3.1C,).   
Brain slices prepared from mice that had undergone 4hr EtOH daily consumption 
for 10 days exhibited no difference in the time of peak neuronal activity compared to brain 
slices prepared from EtOH naïve mice (difference in time-of-peak vs. tissue from EtOH-
naïve mice = -0.77 ± 0.37 n=3, Figure 3.1 E). Likewise, applying 1 mM glutamate alone 
at ZT16 to brain slices from these mice induced a phase delay of ~3 hours (Figure 3.1E), 
consistent with the effects seen in brain slices from EtOH naïve mice. However, as seen 
in Figure 3.1D, co-applying 20mM EtOH and 1mM glutamate to brain slices prepared from 
these mice did not inhibit the glutamate-induced phase shifts. However, increasing the 
concentration of EtOH co-applied with 1mM glutamate to 200 mM completely blocked the 
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glutamate-induced phase shifts in brain slices prepared from the 10-day EtOH drinking 
mice (-0.42 ± 0.30, n=3 Figure 3.1E). Thus 4 hr daily consumption of EtOH for 10 days 
decreased EtOH inhibition of in vitro glutamate-induced phase resetting, consistent with 
the development of chronic tolerance. To more carefully assess the change in EtOH 
sensitivity that occurs with this drinking paradigm, we tested the ability of an intermediate 
concentration of EtOH (150 mM) to inhibit glutamate-induced phase shifts. As seen in 
Figure 3.1E 150 mM EtOH was also unable to inhibit glutamate-induced phase shifts in 
brain slices prepared from these mice.  
Next we investigated how many days of EtOH drinking are needed to induce 
chronic tolerance. As shown in Figure 3.1F 20mM EtOH continued to inhibit glutamate-
induced phase shifts in brain slices after mice had undergone up to 7 days of chronic 
drinking, but not in brain slices from mice that had consumed EtOH for 8 or more days. 
Thus, at least 8 days of drinking EtOH is needed to generate chronic tolerance as 
assessed under these conditions.  
Sensitization to glutamate develops in the SCN during 2 days of withdrawal from EtOH  
Next we investigated the effects of EtOH withdrawal on the SCN circadian clock. 
In this case, we assessed changes in the sensitivity of the SCN circadian clock to 
glutamate induced phase shifts. First we generated a dose response curve for glutamate-
induced phase delays in brain slices from EtOH naïve mice. There was an abrupt shift 
from no phase-shifting response with 1uM glutamate to a maximum ~ 3 h phase delay 
with 10 uM glutamate (Figure 3.2A). In contrast, 1uM glutamate applied to SCN brain 
slices from mice that had undergone EtOH drinking for 21 days followed by 2 days of 
withdrawal induced significant phase shifts of nearly 3 h (2.42 ± 0.36 hrs, n=3) (Figure 
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3.2A). A similar phase-shift was induced by 10 uM glutamate applied to SCN tissue under 
these conditions, indicating that EtOH withdrawal leads to a change in dose 
responsiveness and not a change in the amplitude of the phase-shifting response.   
To assess whether this change in glutamate sensitivity was the result of EtOH 
withdrawal or if it was due to the prior EtOH consumption, we investigated the phase-
shifting effects of glutamate applied to brain slices prepared from mice having undergone 
21 days of ethanol consumption without subsequent EtOH withdrawal. As summarized in 
Figure 3.2A, not only was 1uM glutamate unable to induce phase shifts in these brain 
slices, but a higher (100 uM) concentration of glut was required to induce a phase delay. 
Thus, prior to EtOH withdrawal, the SCN clock appears to be slightly less sensitive to 
glutamate-induced phase shifts while glutamate hypersensitivity develops during the 
period of EtOH withdrawal. 
To clarify the duration of EtOH consumption needed to generate the withdrawal-
associated glutamate hypersensitivity, we varied the number of days of EtOH 
consumption prior to the 2 days of withdrawal. As summarized in Figure 3.2B, withdrawal-
induced glutamate hypersensitivity was seen after 17 or 21 days of chronic EtOH, but not 
after 10 or 14 days. Additionally, we clarified the duration of glutamate hypersensitivity 
after withdrawal. Withdrawal induced glutamate hypersensitivity still occurs after 4 days 
but not after 6 days of EtOH withdrawal (Figure 3.2C). Thus the duration of withdrawal 
associated hypersensitivity lasts between 4-6 days after sudden EtOH abstinence. 
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EtOH-induced changes in NR2A:NR2B ratio, NR2B phosphorylation, and 
upstream/downstream NMDA regulators 
Previously, we determined that total expression of the NMDA receptor subtype 2 
(NR2B) subunit and phosphorylation of the tyrosine 1472 (Y1472) residue of the NR2B 
subunit do not change during rapid tolerance (Lindsay et al 2014). Here we expanded our 
investigation of potential changes in NMDA receptors and related proteins in response to 
varying EtOH exposure and withdrawal paradigms. A summary of the proteins we 
assessed and our results is provided in Table 3.1. We performed Western blot assays on 
SCN tissue from EtOH naïve mice, and from mice receiving 1 night of drinking, 10 days 
or 21 days of 4-hr/day drinking, and 21 days of drinking followed by 2 days of withdrawal. 
As seen in Figure 3.3 A and B, no significant changes were observed with respect to total 
NR2A or NR2B subunit expression in SCN tissue across any of the 5 conditions. 
However, the ratio of NR2B/NR2A expression was significantly higher after 21 days of 
drinking with or without 2 days of withdrawal when compared to SCN tissue from naïve 
mice (21 days: 3.67 ± 0.84 n=7, t4=3.50 p=0.015; withdrawal 3.45 ± 0.57 n=7, t4=3.232, 
p=0.027; Figure 3.3C). We also tested total expression of the NR1 subunit, however no 
changes were noted  (1 ± 0.00 control, 1.21 ± 0.17 overnight, 1.09 ± 0.15 10 day, 1.34 ± 
0.29 21 day, 1.36 ± 0.28 withdrawal; F4=0.552, n=4 for all conditions; data not shown). 
Next we investigated changes in NR2B subunit phosphorylation. Relative to EtOH 
naïve SCN tissue, we found a significant increase compared to control and overnight 
conditions in phosphorylation of NR2B Y1472 in SCN tissue from mice that had 
experienced 21 days of chronic drinking followed by 2 days of withdrawal, but no change 
in other groups (withdrawal: 4.98 ± 1.53 n=8, vs control t4=3.23, p=0.030; vs overnight 
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1.02 ± 0.33 n=8, t4=3.21 p=0.028 Figure 3.4A). We also tested phosphorylation at NR2B 
S1480, however no changes were noted (1 ± 0.00 control, 1.56 ± 0.39 overnight, 1.07 ± 
0.23 10 day, 1.14 ± 0.38 21 day, 1.03 ± 0.33 withdrawal; F4=0.570, n=4 for all conditions 
data not shown). 
Phosphorylation of NMDA receptors has been linked to activation of TrkB 
receptors. More specifically, TrkB phosphorylates and activates Fyn kinase (Yamada and 
Nabeshima 2004; Carreño et al 2011), which leads to increased activation of NMDA 
receptors via Fyn-induced phosphorylation of the NR2B subunits (Nakazawa et al 2001; 
Goebel et al 2005). Binding of mature brain-derived neurotrophic factor (mBDNF) 
activates TrkB, leading to phosphorylation of many residues including Y1472 of the 
NMDA receptor (Mizuno et al 2003). To investigate potential upstream mechanisms 
leading to changes in phosphorylation of NR2B Y1472 during tolerance and withdrawal, 
we investigated changes in pro BDNF and mBDNF expression, truncated TrkB and full 
length TrkB expression, and TrkB phosphorylation in SCN tissue. We found a significant 
increase in mBDNF total expression during withdrawal compared to EtOH naïve controls 
(withdrawal 2.07 ± 0.34, n=6, t4 =3.104, p=0.046; Figure 3.4c). Furthermore an increase 
in pTrkB at Tyr 706 occurred during withdrawal compared to all other conditions 
(withdrawal 2.55 ± 0.50, n=4; vs control t4 =3.401, p=0.039; vs overnight 1.13 ± 0.168 t4 
=3.114, p=0.049; vs 10 day t4 =3.312, p=0.042; t4 =3.231, p=0.044 vs 21 days; Figure 
3.4d). No significant changes were noted for expression of pro BDNF (1 ± 0.00 control, 
1.04 ± 0.16 overnight, 1.14 ± 0.16 10 day, 1.10 ± 0.17 21 day, 1.03 ± 0.10 withdrawal; 
F4=0.185, p=0.94, n=6 for all conditions, data not shown), truncated TrkB (1 ± 0.00 
control, 0.95 ± 0.07 overnight, 0.80 ± 0.24 10 day, 0.84 ± 0.24 21 day, 0.95 ± 0.22 
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withdrawal; F4=0.211, p=0.93, n=4 for all conditions data not shown), nor full length TrkB 
(1 ± 0.00 control, 0.91 ± 0.14 overnight, 1.40 ± 0.45 10 day, 1.01 ± 0.28 21 day, 1.34 ± 
0.29 withdrawal; F4=0.640, p=0.64, n=4 for all conditions, data not shown). 
Lastly with respect to assessing changes in protein expression, we investigated 
two additional proteins whose expression has been linked to changes in glutamate 
signaling: the postsynaptic density scaffolding protein, PSD-95 and the tyrosine kinase, 
Fyn (Roche et al 2001; Prybylowski et al 2005; Trepanier et al 2012; Gibb et al 2011). 
However, we found no significant differences in PSD-95 (1 ± 0.00 control, 1.49 ± 0.27 
overnight, 1.99 ± 0.44 10 day, 1.01 ± 0.28 21 day, 1.34 ± 0.29 withdrawal; F4=1.398, 
p=0.26, n=7 for all conditions, data not shown) and Fyn (1 ± 0.00 control, 1.08 ± 0.10 
overnight, 0.99 ± 0.13 10 day, 1.56 ± 0.24 21 day, 1.88 ± 0.46 withdrawal; F4=1.432, 
p=0.25, n=6 for all conditions, data not shown) across all experimental conditions. 
Increases in phosphorylation of Y1472 are linked to increases in synaptic 
localization of NR2B containing NMDA receptor (Nakazawa et al 2001; Goebel et al 
2005). To test if increases in surface localization of NR2B subunits occur during tolerance 
and withdrawal, we used cell surface biotinylation. Although an increase in Y1472 
phosphorylation was noted during withdrawal treatments, we observed no changes in 
surface expression of NR2B subunits across all conditions (1 ± 0.00 control, 1.24 ± 0.29 
overnight, 1.28 ± 0.27 10 day, 1.32 ± 0.30 21 day, 1.48 ± 0.30 withdrawal, F4=1.069 n=6, 
p=0.39; data not shown).  
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Discussion 
Time course of chronic tolerance and withdrawal 
Previously we demonstrated the SCN develops rapid tolerance after mice were 
given access to EtOH for a single night, and this tolerance is characterized by a decrease 
in EtOH inhibition of photic (in vivo) and glutamate-induced (in vitro) circadian clock phase 
resetting (Lindsay et al 2014). Here we extend these findings to show that the SCN also 
develops chronic tolerance to EtOH and withdrawal-induced glutamate hypersensitivity. 
Chronic tolerance is characterized by a 10-fold right-ward shift in the dose response curve 
for EtOH inhibition of glutamate induced phase delays compared to that seen in SCN 
tissue from EtOH-naïve mice. This shift in sensitivity is similar to that seen previously with 
rapid tolerance (Lindsay et al 2014). Conversely, EtOH withdrawal leads to a 10-fold left-
ward shift in the dose response curve for glutamate induced phase delays. Together with 
our previous demonstration of acute EtOH tolerance in the SCN in vitro (Prosser and 
Glass 2009), these results illustrate that the SCN circadian clock exhibits a high degree 
of EtOH-induced plasticity in its phase-resetting properties. Given that EtOH disrupts 
circadian periodicity and phase resetting (Prosser et al 2008; Prosser and Glass 2009; 
Rosenwasser et al 2005; Seggio et al 2007; Seggio et al 2009; Brager et al 2010), it will 
be important to determine the cellular mechanisms underlying EtOH-induced plasticity in 
the SCN.  
Prior to exploring changes at the cellular level, we sought to clarify the duration of 
EtOH consumption necessary to develop chronic tolerance to EtOH and withdrawal-
induced glutamate hypersensitivity in the SCN. Using the 4-h/day drinking paradigm 
described here, we find that mice need to consume EtOH for at least 8 days to develop 
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chronic tolerance. This is consistent with results from other brain regions (Broadwater et 
al 2011; Matson et al 2014). In contrast, mice need more than 14 days of EtOH 
consumption to develop withdrawal-induced glutamate hypersensitivity in our 
experiments. Previous research suggests that the duration of drinking necessary to 
induce withdrawal hypersensitivity varies across dose and the way EtOH is delivered. For 
instance withdrawal induced convulsions can develop after as few as four days of EtOH 
vapor inhalation (Olive and Becker 2008) or after 1 – 2 weeks of drinking in rodents 
(Roberto et al 2004; Wang et al 2010), with the latter being consistent with the timing of 
withdrawal induced glutamate sensitization seen here. Importantly, we found that chronic 
EtOH drinking without withdrawal does not cause glutamate hypersensitization. Together, 
the differences seen between these drinking paradigms support the hypothesis that 
distinct cellular adaptations underlie the different forms of EtOH tolerance and withdrawal-
induced hypersensitization to glutamate.  
To our knowledge, these are the first data carefully delineating these differences 
in EtOH plasticity. It will be interesting to extend these findings to other brain regions and 
other EtOH exposure modalities. Doing so will help determine whether the distinctions 
shown here are unique to the SCN and these drinking paradigms, or if they are more 
universally applicable. Because both EtOH tolerance and withdrawal can lead to 
increases in EtOH consumption (Schuckit 1994; Brown et al 1998; Bell et al 2001; 
Ciccocioppo et al 2003; Das et al 2016), a better understanding of the distinct dynamic 
cellular processes underlying each of these conditions may improve treatments to 
alleviate or prevent development of alcohol dependence. Importantly, these data illustrate 
that investigating multiple EtOH exposure paradigms in a single experiment can provide 
102  
a more complete picture of EtOH-induced changes than using a single drinking model. 
The data from this study also show the power of using the SCN circadian clock to 
investigate nuanced differences in EtOH effects in the brain.  
Prior results indicated that under a no-choice EtOH drinking protocol, the SCN 
circadian clock in mice does not exhibit chronic tolerance with respect to EtOH inhibition 
of photic phase shifts in vivo in hamsters and mice (Ruby et al 2009; Brager et al 2010). 
Our data here showing chronic tolerance as assessed in vitro raise interesting questions 
regarding the underlying differences. In Brager et al 2010, mice consumed substantially 
higher amounts of EtOH (20g/kg/day vs. 3.36 ± 0.23 g/kg/day in the current study), and 
drinking was not restricted to a 4 h period each day. In addition evidence suggests in an 
in vivo study that 21 days of voluntary EtOH consumption induces no change to phase 
shift conditions (Seggio et al 2009) as opposed to 21 day forced EtOH which inhibits 
phase shifts (Seggio et al 2009; also as in Ruby et al 2009 and Brager et al 2010). Seggio 
et al suggested the phase shifting mechanism is insensitive to chronic voluntary EtOH but 
is sensitive to chronic forced EtOH. Another study by Rosenwasser et al 2014 
demonstrated reduced effects of EtOH on circadian period after sustained high EtOH 
intake which would be consistent with the development of chronic tolerance, but this effect 
seems to differ by sex and strain. Thus the specific EtOH consumption paradigm and 
model used is an important factor to consider for studying chronic EtOH tolerance in the 
SCN. 
 Likewise, in vivo experiments investigating EtOH withdrawal induced changes in 
phase shifts have shown mixed results. For instance, enhanced photic phase shifts are 
seen during withdrawal in hamsters (Ruby et al, 2009), while EtOH withdrawal does not 
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alter photic phase shifts in mice (Brager et al, 2010). In contrast, free-running circadian 
periodicity after withdrawal from 12 days of EtOH exposure is altered in mice, suggesting 
that EtOH continues to affect clock-regulated mechanisms during withdrawal in mice 
(Logan et al 2012). With respect to our results, we showed that withdrawal induced 
hypersensitization to glutamate occurs in the SCN in vitro. Because sensitivity to photic 
phase resetting was not assessed using a range of light intensities in the in vivo 
investigations mentioned above, future experiments assessing withdrawal induced 
hypersensitization to light will be informative. 
Another important difference is that the previous studies investigated photic phase-
resetting in vivo vs. the in vitro glutamate-induced phase resetting used in the present 
study.  Because EtOH affects many areas that directly or indirectly modulate circadian 
clock functioning, the lack of tolerance seen in vivo could reflect changes in EtOH actions 
across multiple regions that counteract or obscure changes occurring in the SCN.  For 
example, The SCN receives serotonin (5-HT) input from the dorsal raphe nucleus that 
inhibits photic phase shifts (Meyer-Bernstein and Morin 1996; Bradbury et al 1997; Meyer-
Bernstein and Morin 1999). EtOH has been shown to modify 5-HT levels in rats, 
increasing 5-HT in the hypothalamus, amygdala, and hippocampus after a 4 week liquid 
diet (Ara and Bano 2015). In contrast, 5-HT levels decrease in rats after 6 hours of 
withdrawal following chronic liquid diets in the cerebral cortex and striatum in one study 
(Uzbay et al 1998), and the hypothalamus, amygdala, and hippocampus in another (Ara 
and Bano 2015). We have shown that acute EtOH modulates serotonergic signaling in 
the SCN, as seen by enhanced serotonergic phase shifts in vitro (Prosser et al 2008), 
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while acute EtOH inhibits serotonergic phase shifts in vivo, likely through extra-SCN 
actions (Ruby et al., 2009).  
Another difference between the data shown here and the previous in vivo study is 
that hypersensitivity to photic phase resetting was not seen in vivo during withdrawal 
(Brager et al., 2010). Again this could be due to the methodological differences mentioned 
above, or to whether the SCN clock is being investigated in vivo vs. in vitro. As with 
chronic tolerance, it will be important to determine what specific difference(s) account for 
the differential observance of hypersensitivity. Because the development of chronic 
tolerance and withdrawal symptoms are thought to be critical steps toward alcohol 
dependence and abuse (Khanna et al, 1991; Radcliffe et al 2006; Wu et al 2010), it will 
be important to further explore the factors that determine whether chronic tolerance is 
seen in the SCN. Importantly, identifying factor(s) that protect the circadian clock from 
exhibiting chronic tolerance and withdrawal hypersensitivity in vivo could provide insight 
into treatments for those dependent on alcohol. 
Hyperexcitation during withdrawal has been reported across many brain regions 
(see Burnett et al 2016). This effect of EtOH withdrawal was described by Finn and 
Crabbe, who suggested that the adaptations that developed in order to offset the effects 
of EtOH are left unopposed during withdrawal, thus leaving neurons in a hyperactive state 
(1997). Withdrawal induced hyperexcitability is thought to contribute to synaptic 
remodeling in the orbital frontal cortex (Badanich et al 2011). Evidence of withdrawal-
induced hyperexcitation is also seen in the basal lateral amygdala (BLA), as indicated by 
shortened paired-pulse ratio intervals and increased medium excitatory post-synaptic 
current (mEPSC) amplitude and frequency occur during withdrawal (Lack et al 2007). 
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Furthermore, differences were noted in mEPSC amplitude and frequency in the BLA 
during chronic drinking versus 24 h of withdrawal (Lack et al 2007), similar to our 
electrophysiological results supporting physiological disparities in chronic EtOH vs EtOH 
withdrawal. Thus hypersensitivity to glutamate in the SCN during withdrawal is consistent 
with hyperexcitable induced states commonly found during EtOH withdrawal in other brain 
regions. 
Unexpectedly, we observed that the SCN clock has a decreased sensitivity to 
glutamate after 21 days of chronic drinking but prior to EtOH withdrawal. This is somewhat 
paradoxical, given the glutamate hypersensitivity is seen during withdrawal. Decreased  
glutamate sensitivity is also not entirely consistent with the increase in NR2B:NR2A ratio 
and decrease in EtOH sensitivity we see with chronic EtOH (discussed below). We put 
forth several possible explanations: 1) AMPA receptors that partially mediate the phase 
shift mechanism become desensitized to glutamate and subsequently internalized during 
chronic EtOH. Some reports have shown that AMPA receptors are needed for phase 
shifts in the SCN (Takeuchi et al 1991; Mizoro et al 2010). Unlike NMDA receptors, AMPA 
receptors become desensitized and internalized after prolonged exposure to glutamate 
(Traynelis et al 2010; Alsaloum et al 2016). Due to chronic EtOH increasing the levels of 
extracellular glutamate, AMPA receptors could become internalized, leading to partial 
desensitization to glutamate during phase shifts as shown in Figure 3.2A. 2) Another 
explanation could be through cytochrome p450, which metabolizes EtOH to 
acetaldehyde. It is possible that chronic EtOH induced neurotoxicity via increases in 
cytochrome p450 2e1 expression (as seen in Zhong et al 2012) causes rapid 
internalization of NMDA receptors (as seen in Goto et al 2006) in the SCN. In support of 
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this, one report shows decreased NMDA receptor sensitivity to glutamate in the ventral 
tegmental area (VTA) after 8 weeks of chronic EtOH (Fitzgerald et al 2012). Yet these 
results are somewhat counterintuitive to our results showing increases in NR2B to NR2A 
ratios given that changes in these ratios promote glutamate sensitization. Perhaps this 
shift in the NR2B:NR2A ratio is indicative of a shift from synaptic NMDA receptors to 
extrasynaptic receptors, which is somewhat indicative of neurotoxicity (Hardingham and 
Bading 2010). (Figure 3.2A) and therefore may promote a partial glutamate 
desensitization in the SCN. 3) Increases in protein expression of glutamate transporters 
could occur during chronic EtOH in the SCN. This change would be somewhat specific to 
the SCN as other articles have reported mixed results. For instance CIE in the nucleus 
accumbens increases glutamate release without altering glutamate transport (Griffin et al 
2015). In the nucleus accumbens and VTA of rats, decreases in protein expression of 
excitatory amino acid transporter-1 but no change in excitatory amino transporter-2 were 
reported during increased glutamate release due to chronic EtOH (Ding et al 2013). 
Additonally, chronic EtOH decreases glutamate transporter-1 levels in the PFC (Sari et al 
2013). Increases in glutamate transporter expression during chronic EtOH could lead to 
clearance of lower levels of glutamate, leading to glutamate induced phase shift 
desensitization in our in vitro experiments.   
As mentioned, many studies have shown increased levels of extracellular 
glutamate in specific brain regions during chronic EtOH exposure (Gass and Olive, 2008; 
Brage et al 2012; Ding et al 2012; Ding et al 2013; Griffin et al 2013). This is thought to 
be due to chronic EtOH inhibition of presynaptic metabotropic glutamate receptors, 
leading to an increase in glutamate release (Simonyi et al 2004). In contrast, recent 
107  
reports demonstrate that astrocytes regulate the amount and timing of extracellular 
glutamate in the SCN (Brancaccio et al 2017). If chronic EtOH alters the release and/or 
reuptake of glutamate in the SCN, it would be interesting to investigate whether this 
involves changes in astrocytic and/or neuronal activity. 
Chronic EtOH consumption increases the NR2B to NR2A ratio in the SCN   
Having determined the EtOH exposure paradigms needed to induce the various 
forms of EtOH-induced plasticity, we began to assess the cellular changes occurring with 
each condition. We focused on NMDA receptors because their activity is necessary for 
photic phase resetting in the SCN (Ding et al 1997; Mintz et al 1999; Wang et al 2008). 
We determined that there is a significant increase in the ratio of NR2B to NR2A subunit 
expression in the SCN after 21 days of drinking that is not seen with either rapid tolerance 
or 10 days of EtOH consumption. This increase in NR2B:NR2A expression is still seen 
during EtOH withdrawal. Therefore, this change in NMDA receptor subunit expression is 
induced during chronic EtOH consumption, but is not necessary for the expression of 
chronic tolerance, which is seen as early as after 10 days of drinking. However, the 
increase in NR2B:NR2A expression could be necessary for withdrawal induced glutamate 
hypersensitivity. Changes in NR2B:NR2A ratios are thought to regulate the threshold for 
synaptic plasticity globally (Philpot et al 1999; Yashiro and Philpot 2008), and have been 
seen following EtOH exposure. An increase in NR2B:NR2A expression was seen in 
hippocampal slices 15 minutes after application of 100mM EtOH (Suvarna et al 2005), 
which would correspond to an acute tolerance paradigm. In contrast, decreased 
NR2B:NR2A expression is seen in rat hippocampal slices following 7 weeks of EtOH 
vapor (Staples et al 2015). Others have observed that changes in NMDA receptor subunit 
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composition in response to chronic EtOH are region specific (Nona et al 2014). With 
respect to the SCN, an increase in NR2B:NR2A expression is consistent with an 
enhanced propensity for glutamate-induced phase shifts because 1) NR2B subunits are 
necessary for glutamate-induced phase shifts (Wang et al 2008) and 2) NR2B-containing 
NMDA receptors have longer decay kinetics than NR2A-containing receptors (Cull-Candy 
and Leszkiewicz 2004). Whether this change in NR2B:NR2A expression is necessary for 
the withdrawal-induced glutamate hypersensitivity will need to be explored in subsequent 
studies. 
 Although we did not see a change in total NR2B subunit expression during either 
chronic EtOH or withdrawal, other EtOH induced changes could be affecting NMDA 
receptor function. For example, chronic drinking increases membrane localization of 
NR2B subunits in many regions (Qiang et al 2007). Moreover, EtOH withdrawal has been 
shown to increase lateral movement of NR2B containing NMDA receptors to extra-
synaptic zones (Clapp et al 2010; Wills et al 2012). Our surface biotinylation experiments 
did not show changes in NR2B surface expression during tolerance nor withdrawal. 
However we noticed a trend towards increased NR2B surface expression during 
withdrawal (data not shown), and haven’t ruled out changes to surface expression of 
NR2B subunits during chronic EtOH and withdrawal. Given this, our NR2B results for 
biotinylation need further validation. In addition our experiments only investigated 
changes to NR2B subunits. Thus other subunits may show changes in surface expression 
during chronic EtOH and withdrawal. Also, although assessing surface expression of 
receptor proteins is a better indicator of potential activity than assessing total expression, 
it still does not discern synaptic vs extrasynaptic protein levels. Given that increases in 
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extrasynaptic NR2B are implicated in multiple neurological diseases (Hardingham and 
Bading 2010; Gladding and Raymond 2011), it would be worthwhile to investigate 
potential changes in NR2B membrane localization in the SCN in response to different 
EtOH exposure paradigms using synaptic fractionation.  
Our results also demonstrated that the increase in the NR2B:NR2A ratio persists 
following 2 days of withdrawal from EtOH. Interestingly, withdrawal after chronic EtOH 
induces hyperexcitability of NMDA receptor related currents in the striatum that lasts up 
to 9 days after cessation of EtOH (Wang et al 2010). In contrast, no changes in NMDA 
receptor EPSCs were noted in the central amygdala after 6-8h of withdrawal following 
chronic EtOH vapor inhalation (Roberto et al 2004), but NMDA receptor-related EPSCs 
are increased in the BLA 24 hours after abstinence from chronic EtOH (Lack et al 2007). 
Thus the duration of withdrawal induced hyperexcitability of NMDA receptor currents, and 
the mechanisms underlying these changes may be region specific. To determine how 
withdrawal modifies NMDA receptor related signals in the SCN, future investigations 
assessing synaptic vs extrasynaptic localization of NR2B subunits should be a priority. 
Increased phosphorylation of Y1472 occurs during EtOH withdrawal  
In addition to changes in receptor subunit composition, NMDA receptor signaling 
is modulated by phosphorylation of specific residues. For example, phosphorylation of 
NR2B Y1472 potentiates NMDA receptor currents, leading to synaptic recruitment of 
NMDA receptors (Nakazawa et al 2001; Goebel et al 2005). Consistent with this, we found 
that during EtOH withdrawal after chronic drinking there is a significant increase in 
phosphorylation of NR2B Y1472 in the SCN. Interestingly, this change is not seen prior 
to EtOH withdrawal, so it appears to be induced by the cessation of EtOH consumption. 
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Increases in Y1472 phosphorylation have previously been seen after chronic EtOH in the 
rat striatum and in the rat hippocampus (Wang et al 2010, Wu et al 2010). Both studies 
also saw no changes in total expression of NR2A and NR2B protein, consistent with our 
findings (Wang et al 2010, Wu et al 2010). Our results showing increased Y1472 
phosphorylation in the SCN is consistent with the glutamate hypersensitivity we observed 
for the SCN circadian clock. Therefore, pharmacological inhibition of Y1472 
phosphorylation during withdrawal may reduce glutamate hypersensitization in the SCN.  
As with the change in NR2B:NR2A ratio, it will be important to assess whether the change 
in Y1472 phosphorylation is necessary for the glutamate hypersensitivity we see during 
EtOH withdrawal. 
Phosphorylation of Y1472 has also been shown to enhance membrane localization 
of NR2B-containing NMDA receptors. Phosphorylation of Y1472 maintains NR2B subunit 
interactions with the PDZ binding domain of PSD-95 (Roche et al 2001; Pryblowski et al 
2005; Zhang et al 2008). This prevents disassociation and subsequent internalization of 
NMDA receptors via clathrin mediated endocytosis (Roche et al 2001; Chung et al 2004). 
Although we did not see any changes in PSD-95 expression, others have likewise shown 
increased Y1472 phosphorylation during withdrawal without a change in PSD-95 
expression (Clapp et al 2010, Staples et al 2015). Yet there is evidence PSD-95 can play 
an important role in EtOH induced plasticity, as PSD-95 KO mice exhbit increased 
behavioral sensitivity to the sedative effects of EtOH (Camp et al 2011). Also, increased 
clustering of PSD-95 and colocalization of NR2B containing NMDA receptors occur during 
chronic EtOH (Chandler et al, 2006; Clapp et al 2010). With respect to our results, 
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colocalization assays may help confirm increases in PSD-95 interactions with NR2B 
during EtOH withdrawal. 
Increases in mBDNF and TrkB phosphorylation occur during withdrawal 
One mechanism through which Y1472 becomes phosphorylated is via TrkB 
signaling. Binding mBDNF to TrkB induces autophosphorylation of the receptor, allowing 
activation of downstream signals. The activation of TrkB is neuroprotective, supporting 
actions that promote neuron survivability (Chao 2003). Our results showed increases in 
expression of mBDNF and phosphorylation of TrkB during withdrawal. Regarding 
mBDNF, a previous study demonstrated increases in total expression after 3h of 
withdrawal to EtOH in the hippocampus and medial prefrontal cortex (Somkuwar et al 
2016). Others have reported mixed results regarding EtOH and BDNF/TrkB interactions 
(e.g., decreased BDNF binding to TrkB in the hippocampus – Kolb et al 2005; increases 
in expression of BDNF, TrkB, and downstream kinases in the striatum – Logrip et al 2008). 
Some have suggested these changes are region specific (Kolb et al 2003; Logrip et al 
2008; but see Davis 2008), and thus the increases in mBDNF shown here may be specific 
to the SCN. Regarding phosphorylation of TrkB during withdrawal, a study assessing fetal 
alcohol syndrome in juvenile mice reported decreases in TrkB phosphorylation (Nona et 
al 2013). Another study investigating EtOH withdrawal in the rat amygdala saw decreases 
in TrkB expression, as well as decreased activation of kinases downstream of TrkB 
signals (Pandey et al 2008). Therefore, increased phosphorylation of TrkB may also be 
specific to the SCN. These results further elucidate the mechanism associated with 
increases in Y1472 of NR2B containing NMDA receptors during EtOH withdrawal in the 
SCN. 
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Cellular mechanisms underlying rapid and chronic tolerance in the SCN are still unknown 
Clearly there is a great deal we still do not know about the cellular changes 
occurring in the SCN in response to EtOH.  For example, other receptors may contribute 
to the effects of EtOH in the SCN. EtOH modifies many glutamate receptors, including α-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA) and kainate 
receptors (Lack et al 2008; Lack et al 2009; Karpyak et al 2012; Corbit et al 2014; Jin et 
al 2014). Beckley et al demonstrated AMPA receptor total expression in the nucleus 
accumbens increases in response to a single 4-hour binge exposure to EtOH (2015). 
Additionally, EtOH enhances signaling by GABA receptors, particularly the ionotrophic 
GABA(A) receptors, and chronic EtOH exposure alters GABA subunit composition 
(Ravindran et al 2007; Liang et al 2007; McElroy et al 2009; Gonzalez et al 2012; 
Lindemeyer et al 2014). We have previously shown that at least some effects of EtOH in 
the SCN involve activation of δ-subunit containing GABA(A) receptors (McElroy et al 
2008). It would also be worthwhile to investigate increases in phosphorylation of Fyn, 
which is down-stream of mBDNF induced TrkB activation (Yamada and Nabeshima 2004; 
Carreño et al 2011). We have demonstrated previously that BDNF prevents EtOH 
inhibition of glutamate-induced phase shifts in EtOH naïve SCN tissue (Lindsay et al 
2014) as well as after induction of acute and rapid tolerance (Prosser and Glass 2009; 
Lindsay et al 2014). It would be worth investigating the mechanisms through which BDNF, 
TrkB and EtOH interact to modulate glutamate-induced phase shifts. Collectively, 
investigating AMPA receptors, GABA(A) receptors, and BDNF/TrkB interactions during 
tolerance and withdrawal in future experiments would likely lead to a greater 
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understanding of the mechanisms associated with these EtOH induced phenomena in 
the SCN.  
Mechanisms upstream or downstream of NMDA receptors could also contribute to 
compensatory mechanisms occurring in response to EtOH. For example, chronic EtOH 
modifies the function of intracellular modulators such as Fyn, glycogen synthase kinase 
3 beta (GSK3β), and STEP-61. Fyn phosphorylates the Y1472 residue and chronic EtOH 
promotes Fyn activation (Trepanier et al 2012; Gibb et al 2011). Though we saw no 
changes in total Fyn expression, it is possible that phosphorylation of Fyn, which activates 
the kinase, may be modulated by EtOH in the SCN. Chronic EtOH increases GSK3β 
activity in the cerebellum, dorsal striatum, and neuronal stem cells (Xu et al 2006; 
Vangipuram and Lyman 2012, Li et al 2013). Chronic EtOH also blocks STEP-61 
dephosphorylation of Y1472 of the NR2B subunit in the striatum during chronic EtOH 
(Darcq et al 2014), but modulation of STEP-61 by EtOH is not seen in all brain regions 
(Darcq et al 2014). Pertaining to circadian rhythms, Fyn and GSK3β either regulate the 
timing of circadian periods or have a role in the photic phase shift mechanism in the SCN 
(Shima et al 2000; Červená et al 2015). The role of STEP-61 has yet to be investigated 
in the SCN. Because EtOH modifies the actions of extracellular glutamate and second 
messengers downstream of NMDA receptors, future investigations will follow up on how 
extracellular glutamate as well as activation and expression of these proteins change 
during tolerance and withdrawal in the SCN.   
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Conclusions 
To gain a better understanding of how EtOH addiction develops and how it can be 
treated, we must understand the dynamic mechanisms that occur as drinking progresses 
from the short term to long term. Although many studies demonstrate specific changes in 
response to a single EtOH exposure paradigm, few compare the behavioral and cellular 
changes across multiple paradigms. Together with our previous studies, we have shown 
that multiple forms of EtOH-induced plasticity occur in the SCN in response to distinct 
EtOH exposure paradigms, and that each likely involves unique cellular mechanisms that 
develop over different timeframes. Here we focused specifically on changes in NMDA 
receptor subunit total expression, phosphorylation, and surface expression across these 
states. We see a shift in the ratio of NR2B to NR2A subunits, and an increase in Y1472 
phosphorylation that may be critical for glutamate hypersensitivity. Continuing this line of 
investigation will enhance our understanding of how alcohol abuse leads to disruptions in 
circadian rhythms. Moreover, the research will fill major knowledge gaps in our 
understanding of the mechanisms that lead to EtOH addiction, which can lead to novel 
treatments for alcohol addiction.  
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Appendix C 
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Figure 3.1 Chronic tolerance to ethanol (EtOH) inhibition of glutamate-induced phase 
delays. (A-D) Shown are the 2-hour mean ± SEM of suprachiasmatic nucleus neuronal 
activity obtained in individual experiments. (A) Extracellular electrophysiological 
recordings in SCN tissue from an EtOH naïve mouse with no drug treatment peak at 
Zeitgeber time (ZT) 6. (B) A 10 min bath application of 1mM glutamate (glu) at ZT16 to 
SCN tissue from an EtOH naïve mouse induces a ~2.5 hour phase delay. (C) Co-
application of 20mM EtOH with 1mM glutamate blocks glutamate induced phase delays 
in SCN tissue from an EtOH naïve mouse, indicating that the glu-induced phase delay is 
inhibited. (D) Co-application of 20mM EtOH and 1mM glutamate does not inhibit 
glutamate induced phase shifts in SCN slices from a mouse that had undergone the 
chronic protocol for 10 days. Horizontal bars: time of lights-off in the animal colony; 
vertical bars: time of drug treatment(s); dotted line: mean time of peak in control 
experiments. (E) Shown are the mean ± SEM phase shifts from experiments involving 
glutamate and EtOH applied to brain slices of mice after 10 days of the chronic drinking 
protocol. Bath application of 1mM glutamate induces significant phase delays. Co-
application of 20mM EtOH does not block phase shifts. Phase shifts still occur with 
150mM EtOH, but are inhibited by 200 mM EtOH n=3-7. (F) Plotted are the mean peak 
(± SEM) change in phase shifts induced in brain slices of mice drinking 15% EtOH for 
differing amounts of time in number of days – then treated with 1mMglutamate + 20mM 
EtOH determines the number of consecutive days of drinking necessary before tolerance 
occurs. 8 days of drinking is needed for 20mM EtOH to no longer inhibit glu-induced 
phase shifts. One-way ANOVA indicated a significant effect of treatment, *Post hoc 
(Holm-Sidak) test indicates p < 0.05 versus control experiments. ** p<0.01 
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Figure 3.2 Sensitization to glutamate in the SCN after EtOH withdrawal. (A) Plotted are 
the mean peak (± SEM) delays after 0uM, 1uM, and 10uM glutamate after no drinking 
(white bars, n=3), 21 days of drinking (gray bars, n=3), and 21 days of drinking with two 
days withdrawal (orange bars, n=3). **Post hoc (Holm-Sidak) test indicates p < 0.01 
versus the 0 uM glutamate EtOH naïve condition. (B) Plotted are the mean peak (± SEM) 
firing rates induced by 1uM glutamate treatment in mice that have undergone 2 days of 
chronic withdrawal from EtOH after varying numbers of days of chronic drinking. **Post 
hoc (Holm-Sidak) test indicates p < 0.01 versus the 10 days of drinking condition. (C) 
Plotted are the mean peak (± SEM) firing rates induced by 1uM glutamate treatment in 
mice that have undergone a varying number of days of chronic withdrawal from EtOH 
after 21 days of chronic drinking. **Post hoc (Holm-Sidak) test indicates p < 0.01 versus 
the 10 days of drinking condition. 
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Table 3.1 Summary of Western blot results comparing tissue from EtOH naïve mice with 
mice exposed to the different EtOH drinking paradigms. Significant changes compared to 
control conditions were noted for the NR2B/NR2A ratio (2B/2A), phosphorylation of the 
NR2B subunit at the Y1472 residue (Y1472), total expression of mBDNF (mBDNF), and 
phosphorylation of TrkB at Y706 residue (pTrkB). All experiments were performed relative 
to actin and normalized to control. <0.05 represent p-values for results with significant 
changes compared to control conditions and ‘x’s represent no significant changes.  
  NR2A NR2B 2B/2A Y1472 pBDNF mBDNF pTrkB 
Overnight x x x x x x x 
10 day x x x x x x x 
21 day x x p<0.05 x x x x 
Withdrawal x x p<0.05 p<0.05 x p<0.05 p<0.05 
 
  NR1 S1480 Fyn PSD95 FL TrkB Trnc TrkB 
Overnight x x x x x x 
10 day x x x x x x 
21 day x x x x x x 
Withdrawal x x x x x x 
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Figure 3.3 Total expression of NR2B, NR2A, and NR2B:NR2A ratio after rapid, chronic 
10 days, chronic 21 days, and withdrawal procedures. (A) Above, plotted are the mean 
band densities (± SEM) for total expression of NR2A normalized to control tissue and 
relative to actin (n=7 for all conditions). Below are representative images for NR2A band 
densities across all treatments, respectively. (B) Above, plotted are the mean band 
densities (± SEM) for total expression of NR2B normalized to control tissue relative to 
actin (21D n=7; other variables n=11). Below are representative images for NR2B band 
densities across all treatments, respectively. (C) Plotted are the mean ratios of band 
densities for NR2B to NR2A total expression normalized to control tissue and relative to 
actin (n=7 for all conditions). Tissue from control untreated mice (ctl), mice drinking 
overnight (RT), mice chronic drinking for 10 days (CT), mice chronic drinking for 21 days 
and mice chronic drinking for 21 days with 2 days withdrawal (WD) treatments to SCN 
slices. *Post hoc (Holm-Sidak) test indicates p<0.05 versus control experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
134  
 
 
 
 
 
 
 
 
 
 
          
     
 
 
 
      
  
Con
trol
Ove
rnig
ht
10 d
ay
21 d
ay
Wit
hdr
awa
lN
R
2A
 p
ro
te
in
 e
xp
re
ss
io
n 
le
ve
l
 (r
el
at
iv
e 
to
 a
ct
in
 n
or
m
al
 to
 c
on
tr
ol
)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
Con
trol
Ove
rnig
ht
10 d
ays
21 d
ays
Wit
hdr
awa
lN
R
2B
 p
ro
te
in
 e
xp
re
ss
io
n 
le
ve
l 
(r
el
at
iv
e 
to
 a
ct
in
 n
or
m
al
 to
 c
on
tr
ol
)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
Con
trol
Ove
rnig
ht
10 d
ay
21 d
ay
Wit
hdr
awa
l
N
R
2B
:N
R
2A
 p
ro
te
in
 e
xp
re
ss
io
n 
ra
tio
 (r
el
at
iv
e 
to
 a
ct
in
 n
or
m
al
 to
 c
on
tr
ol
)
0
1
2
3
4
5
NR2B 
NR2B:NR2A 
A B 
C 
* * 
NR2A 
180 kDa 
42 kDa 
170 kDa 
42 kDa 
135  
Figure 3.4 Total expression of NR2A and PSD-95 after rapid, chronic 10 days, chronic 
21 days, and withdrawal drinking procedures. (A) Plotted are mean band densities (± 
SEM) for Y1472 phosphorylation of the NR2B subunit of the NMDA receptor normalized 
to control tissue and relative to actin across different conditions (n=3 for 21D, n=8 for 
other conditions). Below are representative images for Y1472 band densities across all 
treatments, respectively. *Post hoc (Holm-Sidak) test indicates p<0.05 versus control 
experiments. (B) Plotted are the mean band densities (± SEM) for the ratio of Y1472 
phosphorylation to NR2B total expression normalized to control tissue and relative to 
actin (n=6 for all conditions).  (C) Above, plotted are mean band densities (± SEM) for 
mBDNF total protein expression normalized to control tissue and relative to actin across 
different conditions (n=6 for all conditions). Below are representative images for mBDNF 
band densities across all treatments, respectively *Post hoc (Holm-Sidak) test indicates 
p<0.05 versus control experiments. (D) Above, plotted are mean band densities (± SEM) 
for tyr 706 phosphorylation of the TrkB receptor normalized to control tissue and relative 
to actin across different conditions (n=3 for 21D, n=8 for other conditions). Below are 
representative images for tyr 706 band densities across all treatments, respectively. 
**Post hoc (Holm-Sidak) test indicates p<0.05 versus all conditions.  
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Chapter 4 
General Conclusions 
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Summary of conclusions 
The goals of this research project were to investigate EtOH induced rapid 
tolerance, chronic tolerance, and withdrawal induced sensitization in the SCN, and 
compare the cellular changes induced under each condition. Many research groups 
investigating EtOH-induced responses in the brain utilize only one model for EtOH 
exposure. Although these previous studies have shown that EtOH alters cellular 
processes like glutamate signaling, they provide little insight into the progression of 
changes that develop across different durations of EtOH exposure. Consistent with these 
studies, previous results in our lab demonstrate that EtOH inhibits glutamate signaling in 
the SCN, as assessed by its ability to inhibit glutamate-induced phase-shifts of the SCN 
circadian clock in vitro, as well as inhibiting photic phase resetting in vivo (Prosser 2003). 
We also showed the circadian clock develops acute tolerance to EtOH inhibition of 
glutamate phase shifts in vitro (Prosser and Glass 2009). Based on these results, we 
hypothesized that rapid tolerance, chronic tolerance, and withdrawal induced 
sensitization also occur in the SCN. Furthermore, we believed that the circadian clock 
would be an excellent model system for investigating the cellular changes associated with 
rapid tolerance, chronic tolerance and withdrawal induced sensitization. 
Given that we observed acute EtOH tolerance in the SCN in vitro (Prosser and 
Glass 2009), it seemed surprising that chronic applications of EtOH continue to inhibit 
photic phase shifts in vivo (Rosenwasser et al 2005; Seggio et al 2007; Seggio et al 2009; 
Ruby et al 2009; Brager et al 2010; Brager et al 2011). From this, we wondered whether 
these differences were due to procedural differences in our in vitro vs in vivo 
assessments, or if they were due to the presence or lack of extra-SCN influences under 
139  
the two conditions. With this in mind, we set out to determine whether rapid tolerance, 
chronic tolerance, and withdrawal induced sensitization occur in the SCN, and if they do, 
to determine whether they involve changes in glutamate receptors. We hypothesized that 
EtOH-induced plasticity in the SCN is associated with changes in NR2B containing NMDA 
receptors in the SCN, and that the extent and manner of these changes differ across 
multiple forms of EtOH plasticity.  
In the experiments presented in chapter two, we demonstrated that rapid tolerance 
to EtOH develops within 24 hours of initial EtOH access. This effect is seen with respect 
to both phase delays (ZT16) and phase advances (ZT23), and is exhibited both in vivo 
and in vitro. The dose of EtOH necessary to inhibit glutamate induced phase shifts during 
rapid tolerance is ten-fold the normal amount. Rapid tolerance lasts between 48 and 72 
hours for the phase delays, and between 72 and 96 hours for the phase advances. In 
chapter three, we demonstrated that chronic tolerance can be seen using our in vitro 
phase-resetting paradigm, and that it develops after a minimum of 8 days of drinking. The 
dose of EtOH necessary to inhibit glutamate induced phase shifts during chronic 
tolerance is 10-fold the normal amount, consistent with what we observed with rapid 
tolerance. We also demonstrated that an increased sensitivity to glutamate-induced 
phase shifts is seen in the SCN in vitro when assessed 2 days after EtOH withdrawal 
following at least 14 days of EtOH consumption. This withdrawal induced glutamate 
hypersensitivity is still apparent at 4 days but not at 6 days after abstinence.  
 Having clearly defined the timing and dosing parameters associated with these 
forms of EtOH plasticity, we proceeded to investigate the underlying cellular mechanisms. 
We determined that distinct changes in NMDA receptor subunits accompany the different 
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forms of plasticity in the SCN: an increase in the ratio of NR2B:NR2A subunits is seen 
after 21 days of drinking and during EtOH withdrawal, but not after a single night of forced 
EtOH consumption or even after ten days of drinking using the drinking in the dark 
paradigm. Increased phosphorylation at the NR2B tyrosine1472 (Y1472) residue is seen 
after EtOH withdrawal, but not after 21 days of drinking. Upstream of Y1472 
phosphorylation, we determined increases in mBDNF total protein expression and TrkB 
phosphorylation occur during withdrawal, but not in any other conditions, matching results 
showing Y1472 phosphorylation. Surprisingly, in none of the conditions did we see 
changes in NR1 total protein expression, NR2B S1480 phosphorylation, nor did we see 
changes in PSD-95 and total protein expression of Fyn. Taken together, these results 
demonstrate that distinct physiological and cellular responses accompany each form of 
EtOH tolerance and EtOH withdrawal, and suggest that EtOH-induced plasticity in the 
SCN may differ from that seen in other brain regions.  
 
Rapid tolerance to EtOH develops in the SCN  
Rapid tolerance occurs after acute tolerance and before chronic tolerance. Some 
studies have suggested that the development of rapid tolerance may be a good predictor 
of subsequent chronic tolerance development (Khanna et al 1991a; Wu et al 2001; 
Radcliffe et al 2006). Like the other forms of ETOH tolerance, a decrease in EtOH-
induced hypnotic, motor, and hypothermic effects is seen during rapid tolerance 
(Gilliam 1989; Silveri and Spear 1999). What distinguishes rapid tolerance from other 
forms of EtOH tolerance besides its timing could be the underlying cellular substrates. 
Pharmacologically, blocking NMDA receptors with the selective antagonist, MK-801, 
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blocks behavioral manifestations of rapid tolerance (Khanna et al 1991b; 1993). A 
separate study demonstrated that NR2A knock-outs but not NR2B knock-outs reduce but 
do not eliminate the decreased sleep/sedative effects of EtOH seen during rapid 
tolerance, supporting the notion that NR2A subunits play a role in rapid tolerance to EtOH 
induced sedation (Palachick et al 2008). However, there is no information on changes in 
protein expression and/or phosphorylation of NMDA receptor subunits during rapid 
tolerance. Thus we attempted to identify physiological characteristics and changes in 
NMDA receptor subunits and other proteins that could regulate NMDA receptor function 
during rapid tolerance. 
The findings in chapter two demonstrate that rapid tolerance is exhibited by the 
SCN both in vivo and in vitro 24 hours after access to EtOH. These results are consistent 
with other studies investigating the timing of rapid tolerance development with respect to 
EtOH-induced hypothermia, ataxia, and sleep promotion in various rodent models 
(Khanna et al 1991a; Radcliffe et al 2006; Sharma et al 2014). In our study, the duration 
of rapid tolerance differed between glutamate-induced phase delays and phase 
advances, lasting 48-72 hours and 72-96 hours, respectively. To our knowledge, this is 
the first time the duration of rapid tolerance has been determined. Though we did not 
address why the duration of tolerance differs between phase delays and phase advances, 
these phase-shifting processes have distinct cellular mechanisms that could be 
differentially modified by EtOH tolerance (Gillette and Mitchell 2002).  
 As mentioned, little is known about modulation of NMDA receptors and NMDA 
receptor related signals during rapid tolerance. We hypothesized that proteins that 
regulate NMDA receptor function may be modulated during rapid tolerance. A major 
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component of NMDA receptor regulation is BDNF-induced TrkB activation (Chao 2003; 
Mizuno et al 2003). TrkB phosphorylates and activates Fyn kinase (Yamada and 
Nabeshima 2004; Carreño et al 2011), which leads to increased activation of NMDA 
receptors via Fyn-induced phosphorylation of the NR2B subunits (Nakazawa et al 2001; 
Goebel et al 2005). In the SCN, BDNF signaling is needed for glutamate/photic phase 
shifting (Liang et al 2000; Kim et al 2006; Mou et al 2009; Cooper et al 2017). We have 
demonstrated that application of exogenous BDNF prevents acute EtOH inhibition of 
phase shifts (Prosser et al 2008). We subsequently demonstrated that exogenous BDNF 
prevents EtOH inhibition of glutamatergic phase shifts during rapid tolerance. Despite 
these data pointing to the importance of BDNF/TrkB/NMDA signaling in glutamate-
induced phase shifts, we found no rapid tolerance-associated changes with respect to 
NMDA receptor NR1, NR2A, or NR2B subunit expression, NR2B phosphorylation at 
Y1472, S1303, or S1480, or TrkB, BDNF, PSD-95, and Fyn kinase total expression.  
These results raise a number of possibilities: 1) Rapid tolerance may not involve 
changes in NMDA receptors.  This would mean that the cellular changes underlying rapid 
tolerance are different from those associated with both acute and chronic tolerance (Läck 
et al 2005; Miyakawa et al 1997; Nagy 2008; Roberto et al 2006; Trepanier et al 2012). 
Given the distinct time courses of these different forms of tolerance, this would not be 
especially surprising. 2) Rapid tolerance may involve NMDA receptor-associated 
compensatory responses not investigated here. For example, chronic EtOH induces 
increases in STEP-33 and p38 MAPK, without altering Src, Lyn, and Fyn kinases (Wu 
et al 2010). Though we did not see changes in phosphorylation of NR2B Y1472, it is 
possible STEP-33 and p38 MAPK alter phosphorylation of other residues on NR2B or 
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different subunits of the NMDA receptor during rapid tolerance. On another note, acute 
EtOH typically alters phosphorylation of NR1 subunit residues (Xu et al 2010; Roh et al 
2011). These changes may still be present during rapid tolerance. 3) Compensatory 
responses during rapid tolerance may involve other receptors like GABA(A)δ receptors. 
In support of this, we previously demonstrated the acute actions of EtOH in the SCN 
involve GABA(A)δ receptors (McElroy et al 2009). Future investigations of rapid tolerance 
in the SCN could focus on any of these cellular mechanisms.  
 
Chronic tolerance to EtOH develops in the SCN  
Chronic tolerance takes longer to develop than acute and rapid tolerance. Reports 
have shown chronic tolerance in rodents with respect to EtOH metabolism and EtOH-
induced ataxia after 10 days to 2 weeks of EtOH exposure (Broadwater et al 2011; Matson 
et al 2014). Manifestations of chronic tolerance are also seen after longer durations of 
continued use, including tolerance to the hypnotic effects of EtOH (e.g., 20 days in 
Matthews et al 2008; 60-90 days in Darbra et al 2002; 120+ days in Cagetti et al 2003). 
At the cellular level, long-term EtOH exposure has been shown to induce changes in both 
NMDA and GABA(A) receptor activity. Studies demonstrate that NMDA receptor-
associated Ca2+ currents increase while GABA receptor-associated Cl- currents decrease 
during chronic tolerance, which in both cases can lead to a hyperexcitable state (Iorio et 
al 1992; Buck et al 1991). Although changes in NMDA and GABA receptor signaling are 
seen during both acute and rapid tolerance (Allan and Harris 1987; Buck et al 1991; 
Grover et al 1994; Silveri and Spear 1999; Silveri and Spear 2004), the changes in NMDA- 
and GABA-receptor ion currents appear to occur exclusively during chronic tolerance or 
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at least have yet to be identified in acute and rapid tolerance. These data support the 
conclusion that the mechanisms underlying acute and rapid EtOH tolerance vs. chronic 
EtOH tolerance are distinct.  
It is possible that the shorter duration of EtOH exposure associated with acute and 
rapid tolerance only allows for changes in the activity of second messengers, while 
chronic EtOH exposure allows for transcriptional/translational changes (Kalant 1996; 
Pietrzykowski and Treistman 2008). Thus, total expression of receptor subunits and 
phosphorylation of key residues of NMDA receptor and GABA receptor subunits are seen 
during chronic EtOH tolerance while they have not been reported during acute and rapid 
tolerance. Specifically, increases in NR2B expression and phosphorylation (Suvarna et 
al 2005; Wang et al 2011), increases in surface localization of GABA α4 subunits (Liang 
et al 2007), and increases in GABA β2 and γ2 subunit phosphorylation have been 
reported during chronic tolerance (Ravindran & Ticku 2006). Importantly however, none 
of these prior studies compared multiple forms of EtOH-induced plasticity within a single 
study, which makes drawing clear distinctions between their cellular substrates more 
difficult.  
Our electrophysiological results show that the SCN develops chronic tolerance to 
EtOH as seen by a decrease in EtOH inhibition of glutamate-induced phase shifts in vitro. 
This is similar to our in vitro results regarding acute and rapid tolerance in the SCN 
(Prosser and Glass 2009). However, this differs from in vivo studies showing that chronic 
EtOH continues to inhibit photic phase shifts (Ruby et al 2009; Brager et al 2010). In 
comparing these in vivo studies with our in vitro experiments there are a few 
methodological differences. In the previous studies, the mice had higher daily EtOH 
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consumptions (20g/kg/day vs. 2.84g/kg/day), they were drinking EtOH for a longer overall 
period (14 days vs. our 10 days), drinking was not restricted to 4 h each day, and 
tolerance was not assessed using different intensities of the phase-shifting stimulus 
(light). A separate study demonstrated that chronic forced EtOH consumption, where 
more EtOH is consumed, inhibits photic phase delays in vivo, while chronic voluntary 
consumption, where less EtOH is consumed, does not inhibit phase shifts (Seggio et al 
2009). With this in mind, a study in our lab suggests that EtOH also enhances 
serotonergic phase shifts, and that this occurs at least in part through inhibiting 
glutamatergic signaling (Prosser et al 2008). Interestingly, serotonin receptors have been 
shown to regulate glutamate release into the SCN (Pickard et al 1996; Smith et al 2001; 
Sprouse et al 2004). Therefore, the effects of EtOH in the SCN may include increasing 
serotonergic signaling and decreasing glutamate release. This is supported by reports 
showing increased serotonin 1a receptor sensitivity during chronic EtOH (Esteban et al 
2001). Thus, in vivo experiments would show results consistent with glutamatergic phase 
shift inhibition during chronic EtOH at higher EtOH concentrations, but not at lower EtOH 
concentrations as assessed in Seggio et al 2009. It will be important to further explore the 
critical variables determining whether chronic tolerance is seen in the SCN in vivo. 
Importantly, identifying factor(s) such as serotonin that potentially protect the circadian 
clock from exhibiting chronic tolerance in vivo could provide insight into treatments for 
those dependent on alcohol. 
As with rapid tolerance, we characterized the change in sensitivity and timing 
parameters of both chronic tolerance and withdrawal induced glutamate hypersensitivity. 
We determined that chronic tolerance is characterized by a 10 fold right-ward shift in the 
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dose response curve for EtOH inhibition of glutamate induced phase shifts, similar to the 
changes in sensitivity seen with rapid tolerance. We also determined that, using our 
assessment protocol, it takes 8 days of drinking to develop chronic tolerance. To our 
knowledge, this is the first experiment to carefully assess how many days of consecutive 
drinking are necessary for chronic tolerance to develop. Previous studies have sometimes 
used 7-14 days of EtOH consumption to investigate chronic tolerance (Broadwater et al 
2011; Matson et al 2014).  Although this duration of EtOH exposure is generally consistent 
with our results, it might be worthwhile for researchers to adopt a paradigm that includes 
at least 8 days of EtOH consumption when investigating chronic tolerance.  
There are still many unanswered questions regarding the cellular changes 
associated with chronic tolerance. As with rapid tolerance, it is possible that chronic 
tolerance does not require changes in NMDA receptor expression. Although other studies 
have reported changes in NMDA receptors during chronic tolerance (Nagy 2008; Roberto 
et al 2006; Wu et al 2010), most involved much longer periods of EtOH exposure. So it is 
not clear whether the changes induced in the SCN by chronic EtOH exposure differ from 
those of other regions or whether the difference is due to different durations of EtOH 
exposure. A second possibility is that chronic tolerance in the SCN involves changes in 
other receptors. Many reports have demonstrated modulation of GABA(A) receptors and 
AMPA receptors during chronic EtOH tolerance in the amygdala and cortex (Liang et al 
2007; Ravindran et al 2007; Liang et al 2009; Lindemeyer et al 2014; Nimitvilai et al 2016; 
see below). Chronic tolerance may also involve processes upstream and/or downstream 
of NMDA receptors that were not investigated here. We saw no changes in total 
expression of Fyn, however other reports have demonstrated that phosphorylation of Fyn 
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is increased during chronic EtOH (Gibb et al 2011). Seeing that our results demonstrated 
increases in mBDNF and TrkB phosphorylation during withdrawal, increased 
phosphorylation of Fyn via TrkB signals during withdrawal is likely. Finally, we did not 
assess glutamate levels in the SCN, but others have reported increases in extracellular 
glutamate associated with chronic EtOH exposure (Rossetti and Carboni, 1995; Ding et 
al 2012; Ding et al 2013; Griffin et al 2013), which could affect signaling in the SCN 
through homeostatic synaptic changes. Investigating these possibilities should help 
distinguish the cellular changes associated with chronic tolerance from those of other 
forms of tolerance. 
 
Withdrawal from EtOH increases circadian clock sensitivity to glutamate-induced 
phase resetting. 
The behavioral effects of withdrawal from EtOH are distinct from those associated 
with EtOH tolerance. For example, withdrawal can lead to insomnia, psychomotor 
agitation, hallucination, and seizures (Schuckit 2014), while tolerance is primarily 
characterized by a loss or reduction in EtOH-induced behaviors, such as decreased EtOH 
induced sleep, ataxia, and hypothermia (Khanna et al 1991a; Radcliffe et al 2006; Sharma 
et al 2014). Nevertheless, the cellular changes seen with EtOH withdrawal and EtOH 
tolerance overlap. Some studies have demonstrated that withdrawal is associated with 
increases in extracellular glutamate (Ding et al 2013; Griffin et al 2013), a response also 
seen during chronic EtOH (Roberto et al 2004; Christian et al 2013). Conversely, studies 
investigating the hippocampus and bed nucleus of the stria terminalis (BNST) have shown 
that synaptic localization of NR2B subunits decreases during EtOH withdrawal (Clapp et 
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al 2010; Wills et al 2012), which contrasts with increased synaptic localization of NR2B 
subunits during chronic EtOH (Clapp et al 2010). With this in mind, we assessed the same 
glutamate signaling-associated proteins during EtOH withdrawal as we assessed after 
rapid and chronic tolerance. 
We determined that glutamate hypersensitivity, characterized by a 10 fold left-ward 
shift in the dose response curve for glutamate induced phase delays, is seen after at least 
14 days of EtOH consumption followed by 2-6 days of EtOH withdrawal. Others have 
shown that withdrawal induced convulsions can develop after as few as four days of EtOH 
vapor inhalation in mice (Olive and Becker 2008), although this paradigm involves a more 
intensive exposure to EtOH and thus potentially much higher blood ethanol concentration 
levels than the drinking in the dark paradigm we used. Others have shown EtOH 
withdrawal associated seizures after EtOH drinking for 2 weeks (Roberto et al 2004) or 
1-2 weeks (Wang et al 2010) in rodent models, which is more consistent with our results. 
Some studies have reported EtOH withdrawal induced convulsions lasting as little as 4-
10 hours after EtOH withdrawal (Farook et al 2008; Olive and Becker 2008) while other 
effects, such as locomotor sensitization, last upwards of 11 days after EtOH withdrawal 
(Abrahao et al 2013). Importantly, our data showing that chronic drinking prior to 
withdrawal does not lead to glutamate hypersensitization is consistent with other studies. 
This suggests that withdrawal induced plasticity requires a period of abstinence to 
develop.  
The increase in NR2B:NR2A expression we observed after 21 days of drinking is 
still seen during EtOH withdrawal. This increase could be one component of the 
mechanism underlying withdrawal induced glutamate hypersensitivity. Only after 
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withdrawal did we also see an increase in phosphorylation of the NR2B Y1472 residue. 
Increases in the phosphorylation of NR2B Y1472 potentiate NMDA receptor currents and 
lead to synaptic membrane recruitment of these receptors (Nakazawa et al 2001; Goebel 
et al 2005). Once the NMDA receptors are localized to the membrane, phosphorylation 
of Y1472 also maintains their localization within the synapse (Goebel et al 2005) via 
interactions with the scaffolding protein, PSD-95 (Roche et al 2001; Prybylowski et al 
2005; Zhang et al 2008). These changes are associated with hyperexcitable states in 
neurons and have been demonstrated in other brain regions during EtOH withdrawal. For 
example, increases in NR2B Y1472 in the hippocampus and the dorsomedial striatum 
have been reported during EtOH withdrawal (Pawlak et al 2005; Wang et al 2010). Thus, 
the glutamate hypersensitivity seen during withdrawal could be due to a combination of 
increased NR2B:NR2A expression and increased NR2B Y1472 phosphorylation. These 
changes would be expected to increase NMDA receptor excitatory postsynaptic potentials 
as seen in the amygdala, dorsomedial striatum and hippocampus (Roberto et al 2004; 
Wang et al 2010; Wu et al 2010). An important test of this scenario would be to investigate 
synaptic localization of NR2B containing NMDA receptors during EtOH withdrawal. 
Although we did follow up using cell surface biotinylation, we did not see a significant 
increase with respect to NR2B subunit surface expression (n=6, data not shown). 
However, these results did show trending increases in NR2B surface expression during 
withdrawal. Therefore, we cannot exclude the possibility that chronic EtOH and 
withdrawal modulate surface expression of NMDA receptor subunits. 
One mechanism through which Y1472 phosphorylation occurs is via TrkB receptor 
activation. proBDNF becomes cleaved to generate its mature form by many proteins, 
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including plasmin after its activation by tissue plasminogen activator (tPA) (Pang et al 
2004). Mature BDNF is then capable of binding TrkB, inducing TrkB dimerization, and 
allowing autophosphorylation. We showed an increase in mBDNF total protein expression 
during withdrawal, which is consistent with tPA dependent increases in Y1472 during 
EtOH withdrawal (Pawlak et al 2005). Furthermore, an increase in phosphorylated TrkB 
at Tyr 706 occurred during withdrawal. Other studies have demonstrated similar results. 
For instance, increases in BDNF protein expression have been reported in the rat 
hippocampus and medial prefrontal cortex after a 3h withdrawal from chronic intermittent 
ethanol ([CIE], Somkuwar et al 2016). Another investigation in the mouse dorsal lateral 
striatum showed that p75, a neurotrophin factor receptor that pro BDNF binds and 
opposes TrkB signals, increases after cessation of 21 days of 2 bottle access CIE for 24 
h, suggesting EtOH withdrawal induces neuroadaptive responses (Darcq et al 2016). Yet 
we showed increases in TrkB phosphorylation, suggesting withdrawal induced 
sensitization to glutamate in the SCN is acting through TrkB signals. Others have shown 
that acute ethanol blocks TrkB phosphorylation mediated NR2B containing NMDA 
receptor activation (Kolb et al 2005). Thus the nature of this response may be 
compensatory, as the removal of EtOH due to withdrawal may leave previous inhibition 
of TrkB phosphorylation by EtOH unchecked (see Figure 4.1).  
 We have summarized our data demonstrating changes in the glutamatergic phase 
shift mechanism across control conditions, overnight/10 day chronic drinking, 21 day 
chronic drinking, and 21 days of drinking followed by withdrawal (Figure 4.1). The 
changes across each condition are represented in a timeline to gain perspective on when 
each EtOH induced plasticity develops.  
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Future directions 
Ethanol-induced plasticity  
We demonstrated that rapid tolerance, chronic tolerance, and withdrawal 
hypersensitivity all occur in the SCN. However, we were unsuccessful in fully delineating 
the cellular mechanisms contributing to these responses. We believe it is likely that 
additional receptors participate in these phenomena.  Some likely candidates are 
discussed below.  
GABA(A) receptors 
GABA(A) receptors reduce neuronal activation throughout the brain, and generally 
act to counteract glutamate-induced excitation. In the SCN pharmacological inhibition of 
GABA(A) receptors can enhance photic/glutamate phase shifts, while GABA(A) receptor 
activation can inhibit these phase shifts, confirming GABA(A) receptor regulation of photic 
phase shifts (Ralph and Menaker 1989; Gillespie et al. 1997; Herzog et al 2017). GABA(A) 
receptors contain 5 total subunits, with the most common isoforms including 2 α subunits, 
2 β subunits, and either a γ or δ subunit (Olsen and Sieghart 2009). The α and β subunits 
are important for regulating ion channel conductance properties, while the γ and δ 
subunits regulate the localization of GABA receptors in and out of the synaptic active 
zone, respectively. The characteristics of γ and δ containing-GABA(A) receptors also 
differ in that they generate phasic and tonic currents, respectively (Farrant and Nusser 
2005).  
 Post-translational modifications such as phosphorylation contribute to the 
regulation of GABA(A) receptors. Phosphorylation of key residues of different subunits of 
GABA(A) receptors modify localization to the membrane and receptor kinetics (Abramian 
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et al 2010; Bright and Smart 2013; Bohnsack et al 2016). Therefore, post-translational 
modifications of GABA(A) receptors can lead to substantial changes in the regulation of 
neuronal activity.  
As with glutamate signaling, EtOH modifies GABA signaling in a manner that 
differs based on the duration of EtOH exposure. Acute EtOH enhances GABA receptor 
ion conductance (Wei et al 2004; Olsen et al 2007), while chronic EtOH reduces GABA 
receptor activation and expression, and alters phosphorylation of GABA(A) subunits 
(Kumar et al 2003; Liang et al 2007; Bright and Smart 2013; Abramian et al 2010; Ron 
and Messing 2013). EtOH can also modify the function of kinases and phosphatases that 
regulate GABA(A) receptor mobilization to and from the membrane (Brandon et al 2000; 
Brandon et al 2003; Carlson et al 2013; Carlson et al 2014; Choi et al 2008; Kumar et al 
2010). Changes in GABA(A) receptors have been shown during acute, rapid, and chronic 
tolerance, including changes in GABA(A) receptor currents, subunit expression, and 
phosphorylation (Allan and Harris 1987; Buck et al 1991; Barbosa and Morato 2001; 
Ravindran et al 2007, Liang et al 2007, Gonzalez et al 2012, Lindemeyer et al 2014). One 
target of EtOH induced effects we are especially interested in exploring is δ subunit 
containing GABA(A) receptors. Previously we showed that application of R015-4513, a 
GABA(A) δ subunit selective antagonist, prevents EtOH inhibition of glutamate induced 
phase delays, suggesting that EtOH acts in part on GABA(A) receptors to inhibit photic 
phase shifts (McElroy et al 2009). Following up on these experiments by investigating 
potential changes in the expression levels and localization of GABA(A) δ subunits during 
EtOH tolerance and withdrawal may reveal more on these tolerance mechanisms.  
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AMPA receptors 
Glutamatergic AMPA receptors contribute substantially to regulating neuronal 
excitation. Each AMPA receptor is composed of 4 subunits, forming a heterotetramer that 
assembles in a ‘dimer of dimers’ configuration (Mayer 2005). The different subunit types 
include GluR1-R4 and always assemble in pairs. Phosphorylation of these receptors 
modifies membrane localization, ion channel conductance, and the probability the 
channel is open (Derkach et al 1999; Banke et al 2000; Hayashi et al 2000; Boehm et al 
2006). Some studies have demonstrated that in vivo and in vitro applications of AMPA 
phase shift the clock, suggesting an important role for AMPA receptors in photic phase 
shift mechanisms (Takeuchi et al 1991; Mizoro et al 2010).  
Many reports have shown that EtOH modulates AMPA receptors. Though not as 
sensitive to acute EtOH as NMDA receptors (Möykkynen and Korpi 2012), acute EtOH 
inhibits AMPA receptor currents in adolescent rodents (Zhu et al 2007; Puglia and 
Valenzuela 2010). In contrast, chronic EtOH enhances the amplitude of AMPA receptor 
small excitatory postsynaptic currents in the basolateral amygdala of rats (Läck et al 
2007). Chronic EtOH and EtOH withdrawal also alter AMPA subunit expression, subunit 
trafficking, and phosphorylation in the rodent amygdala and cortex (Christian et al 2012; 
Agoglia et al 2015; Nimitvilai et al 2016; Salling et al 2016). Regarding EtOH tolerance, 
AMPA receptor antagonists block formation of rapid tolerance associated with motor 
coordination behaviors in mice (Rial et al 2009). Also, chronic intermittent EtOH 
suppresses acute EtOH inhibition of AMPA receptor induced potentials in the orbitofrontal 
cortex of mice, suggesting AMPA receptors contribute to tolerance (Nimitvilai et al 2016). 
Because chronic EtOH and EtOH withdrawal modulate phosphorylation, trafficking, and 
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conductance of the AMPA receptor, AMPA receptors would be worth investigating using 
our multiple model approach.  
Serotonin Receptors 
Serotonin (5-HT) receptors mediate a variety of neurological processes including 
learning and memory, mood, and locomotion. In the SCN, 5-HT receptors mediate non-
photic phase shifts (Medanic and Gillette 1992; Prosser 2003; Sprouse et al 2004).  5-HT 
receptors can also modify SCN responses to light, particularly the 5-HT1A, 5-HT1B, 5-
HT3, 5-HT5A, and 5-HT7 receptor subtypes. These receptors modulate SCN neuron 
activity via inputs from other regions and within the SCN. For example, applying the 
selective 5-HT1B receptor agonist TFMPP to the SCN inhibits light induced phase shifts 
by reducing presynaptic glutamate release (Pickard et al 1997), while 5-HT1B KO mice 
have reduced responses to photic phase shifts (Sollars et al 2006). Activation of 5HT3 
receptors on retinohypothalamic tract terminals induces photic phase shifts by increasing 
the release of glutamate on to SCN neurons (Graff et al 2006). In contrast, activation of 
5-HT7 receptors in SCN neurons reduces amplitude of excitatory post-synaptic currents, 
and thus inhibits postsynaptic glutamate responses in the SCN (Smith et al 2001; Sprouse 
et al 2004). 
EtOH also affects serotonin receptor function, particularly 5-HT1A, 5-HT1B, and 5-
HT3 receptor subtypes, and the effects of EtOH differ depending on exposure duration. 
Behaviorally, mice with 5HT1A and 5HT1B receptor knockouts have increases in EtOH 
consumption and EtOH intoxication (Lovinger 1997). Acute EtOH also enhances 5-HT3 
receptor activation (Vengeliene et al 2008). Conversely, chronic EtOH increases 
expression of the 5-HT1A (Burnett et al 2014) and 5-HT1B receptors in the macaque 
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hippocampus (Pandey et al 1996). Unfortunately, little is known about the effects of 
chronic EtOH on 5-HT3 receptors, although recent evidence shows that alcoholic patients 
have increased 5-HT3 receptor A subunit mRNA expression compared to non-alcoholics 
(Xu et al 2016). It appears that no research has been done on the effects of chronic EtOH 
and EtOH withdrawal on 5-HT3 receptors. Because acute and chronic EtOH alter 
serotonin receptor subtypes critical for regulating phase resetting in the SCN, it would be 
worthwhile to investigate changes in these receptors during EtOH tolerance and 
withdrawal. 
The effects of EtOH metabolites in the SCN 
Acetaldehyde, the first metabolite of EtOH metabolized from cytochrome p450 in 
the brain, causes many problems associated with EtOH abuse. For example, 
acetaldehyde accumulation is neurotoxic (Takeuchi et al 2003), can promote spreading 
of tumors by inhibiting DNA repair (Seitz and Meuller 2015), and induces addictive like 
behavior in animal models by activating dopamine neuron firing in the mesolimbic system 
(Foddai et al 2004; Deehan et al 2013; Brancato et al 2014). The effects of acetaldehyde 
on dopamine neurons in the ventral tegmental area are thought to occur by modulation 
of A-type K+ currents and shortening the interval between hyperpolarization-activated 
inward rectifying currents (Melis et al 2007). A-type K+ channels are also found in the 
SCN, where they regulate SCN neuron excitability (Itri et al 2010; Granados-Fuentes et 
al 2012). Thus, it is possible that at least some of our effects are caused by acetaldehyde 
rather than EtOH. To test this, we could co-apply catalase inhibitors with glutamate and 
EtOH to the SCN in vitro during the early or late night. If the glutamate-induced phase 
shifts are not blocked, this would suggest glutamate phase shift inhibition involves 
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acetaldehyde. Follow-up experiments could also investigate whether tolerance to 
inhibition of phase shifts and withdrawal induced sensitization to glutamate is induced by 
drinking an acetaldehyde/water solution at various concentrations, depending on the type 
of tolerance or sensitization under question. 
Astroglia and glutamate release 
A recent paper by Brancaccio et al., (2017) showed that the timing of extracellular 
glutamate release is pivotal for maintaining circadian timekeeping. During the night, the 
level of extracellular glutamate peaks in the SCN, a process controlled by astrocytes. 
Other players in this mechanism include excitatory amino acid transporters (EAAT) 
responsible for glutamate reuptake, and NR2C containing NMDA receptors that may be 
located on GABAergic presynaptic terminals, which would allow the extracellular 
glutamate to regulate GABA release (Brancaccio et al 2017). As in other brain regions 
(Gass and Olive, 2008; Brager et al 2012; Ding et al 2012; Ding et al 2013; Griffin et al 
2013) chronic EtOH could modulate extracellular glutamate levels in in the SCN. 
Experiments assessing potential changes in total expression of EAAT and NR2C subunits 
during EtOH tolerance and withdrawal, as well as extracellular glutamate levels, could 
provide evidence for this possibility. 
 
Conclusions 
 We have demonstrated the utility of the SCN as a model system for investigating 
EtOH. Not only does EtOH have clearly identified acute effects both in vivo and in vitro, 
but multiple forms of EtOH-induced plasticity develop in the SCN in response to different 
drinking paradigms. While many labs have investigated the cellular changes that occur 
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during tolerance, none have demonstrated changes across multiple forms of tolerance as 
well as withdrawal induced sensitization within a cohesive set of experiments.  
Many studies, including this one, have demonstrated that the effects of EtOH are 
extremely varied, across time and across brain region. In light of this, future investigations 
evaluating novel targets for AUD should consider using multiple drinking models that 
compare different drinking durations. Assessing the effects using a single paradigm may 
reveal only some of the critical changes induced by EtOH consumption, and may limit the 
translational potential of the research.  
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Figure 4.1 The timeline of overnight/10 days of EtOH, 21 days of EtOH, and EtOH 
withdrawal in the SCN. Under normal conditions, the glutamate light in vivo or glutamate 
in vitro phase shifts the clock during the early night (phase delays) or late night (phase 
advances). Further down the timeline represents the development of rapid tolerance and 
chronic tolerance after an overnight binge or 4h access for ten days. SCN tissue becomes 
tolerant to inhibitory effects of EtOH during these conditions. The cellular actions that 
promote this response are still under consideration and thus no figures represent these 
two EtOH induced plasticities. Next, After 21 days of 4h EtOH access, EtOH induced 
plasticity leads to an increase in the ratio of total protein expression of NR2B to NR2A. 
Though this change is not required for tolerance as an increase in the NR2B to NR2A 
expression ratio does not occur within the timeframe for tolerance development (overnight 
for rapid or 10 days of 4h access for chronic), it may be a prerequisite of EtOH withdrawal 
induced plasticity. During withdrawal (dotted line on the timeline), less glutamate is 
needed to induce phase shifts, which is evident of EtOH withdrawal induced 
hypersensitization to glutamate. At the cellular level, increases in the NR2B:NR2A ratio 
persist in addition to increases in phosphorylation of the Y1472 residue of the NR2B 
subunit. Upstream, increases in total protein expression of mBDNF and phosphorylation 
of Tyr 706 of TrkB receptors likely promote the increase in Y1472 phosphorylation. These 
changes may be in part due to prolonged and sudden abstinence from EtOH, allowing for 
compensation at the level of TrkB and NMDA receptor signals, and thus leading to SCN 
neuron hyperexcitation. These changes should promote increases in synaptic NR2B-
containing NMDA receptors as well as other receptors and second messengers that were 
not assessed in this project.  
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